<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes - Jones, LV - 2019 | Cochrane Library</title> <meta content="Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes - Jones, LV - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009613.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes - Jones, LV - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009613.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009613.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes" name="citation_title"/> <meta content="Leanne V Jones" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="Amita Ray" name="citation_author"/> <meta content="DM Wayanad Institute of Medical Sciences" name="citation_author_institution"/> <meta content="Foong Ming Moy" name="citation_author"/> <meta content="Faculty of Medicine, University of Malaya" name="citation_author_institution"/> <meta content="moyfm@um.edu.my" name="citation_author_email"/> <meta content="Brian S Buckley" name="citation_author"/> <meta content="University of the Philippines, Manila" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD009613.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/23" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009613.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009613.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009613.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Blood Glucose [*metabolism]; Blood Glucose Self-Monitoring [*methods]; Canada; Diabetes Mellitus, Type 1 [*blood]; Diabetes Mellitus, Type 2 [*blood]; Europe; Hypertension [prevention &amp; control]; Hypoglycemia [chemically induced]; Perinatal Mortality; Pre-Eclampsia [prevention &amp; control]; United States" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009613.pub4&amp;doi=10.1002/14651858.CD009613.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009613\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009613\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","pt","th","ms","ja","fr","zh_HANS","de","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009613.pub4",title:"Techniques of monitoring blood glucose during pregnancy for women with pre\\u2010existing diabetes",firstPublishedDate:"May 23, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009613.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009613.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009613.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009613.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009613.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009613.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009613.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009613.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009613.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009613.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>8846 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009613.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0143"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0095"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-sec-0137"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/appendices#CD009613-sec-0148"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/table_n/CD009613StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/table_n/CD009613StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#CD009613-cr-0002">Leanne V Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#CD009613-cr-0003">Amita Ray</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#CD009613-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Foong Ming Moy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information#CD009613-cr-0005">Brian S Buckley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information/en#CD009613-sec-0153">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 23 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009613.pub4">https://doi.org/10.1002/14651858.CD009613.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009613-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009613-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009613-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009613-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009613-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD009613-abs-0002">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009613-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009613-abs-0001" lang="en"> <section id="CD009613-sec-0001"> <h3 class="title" id="CD009613-sec-0001">Background</h3> <p>There are a number of ways of monitoring blood glucose in women with diabetes during pregnancy, with self‐monitoring of blood glucose (SMBG) recommended as a key component of the management plan. No existing systematic reviews consider the benefits/effectiveness of different techniques of blood glucose monitoring on maternal and infant outcomes among pregnant women with pre‐existing diabetes. The effectiveness of the various monitoring techniques is unclear. This review is an update of a review that was first published in 2014 and subsequently updated in 2017. </p> </section> <section id="CD009613-sec-0002"> <h3 class="title" id="CD009613-sec-0002">Objectives</h3> <p>To compare techniques of blood glucose monitoring and their impact on maternal and infant outcomes among pregnant women with pre‐existing diabetes. </p> </section> <section id="CD009613-sec-0003"> <h3 class="title" id="CD009613-sec-0003">Search methods</h3> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (1 November 2018), and reference lists of retrieved studies. </p> </section> <section id="CD009613-sec-0004"> <h3 class="title" id="CD009613-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) and quasi‐RCTs comparing techniques of blood glucose monitoring including SMBG, continuous glucose monitoring (CGM), automated telemedicine monitoring or clinic monitoring among pregnant women with pre‐existing diabetes mellitus (type 1 or type 2). Trials investigating timing and frequency of monitoring were also eligible for inclusion. RCTs using a cluster‐randomised design were eligible for inclusion but none were identified. </p> </section> <section id="CD009613-sec-0005"> <h3 class="title" id="CD009613-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of included studies. Data were checked for accuracy. The quality of the evidence was assessed using the GRADE approach. </p> </section> <section id="CD009613-sec-0006"> <h3 class="title" id="CD009613-sec-0006">Main results</h3> <p>This review update includes a total of 12 trials (944) women (type 1 diabetes: 660 women; type 2 diabetes: 113 women; type 1 or type 2 (unspecified): 171 women. The trials took place in Europe, the USA and Canada. Three of the 12 included studies are at low risk of bias, eight studies are at moderate risk of bias, and one study is at high risk of bias. Four trials reported that they were provided with the continuous glucose monitors free of charge or at a reduced cost by the manufacturer. </p> <p><b>Continuous glucose monitoring (CGM) versus intermittent glucose monitoring, (four studies, 609 women)</b> </p> <p>CGM may reduce hypertensive disorders of pregnancy (pre‐eclampsia and pregnancy‐induced hypertension) (risk ratio (RR) 0.58, 95% confidence interval (CI) 0.39 to 0.85; 2 studies, 384 women; low‐quality evidence), although it should be noted that only two of the four relevant studies reported data for this composite outcome. Conversely, this did not translate into a clear reduction for pre‐eclampsia (RR 0.65, 95% CI 0.39 to 1.08; 4 studies, 609 women, moderate‐quality evidence). There was also no clear reduction in caesarean section (average RR 0.94, 95% CI 0.75 to 1.18; 3 studies, 427 women; I<sup>2</sup> = 41%; moderate‐quality evidence) or large‐for‐gestational age (average RR 0.84, 95% CI 0.57 to 1.26; 3 studies, 421 women; I<sup>2</sup> = 70%; low‐quality evidence) with CGM. There was not enough evidence to assess perinatal mortality (RR 0.82, 95% CI 0.05 to 12.61, 71 infants, 1 study; low‐quality evidence), or mortality or morbidity composite (RR 0.80, 95% CI 0.61 to 1.06; 1 study, 200 women) as the evidence was based on single studies of low quality. CGM appears to reduce neonatal hypoglycaemia (RR 0.66, 95% CI 0.48 to 0.93; 3 studies, 428 infants). Neurosensory disability was not reported. </p> <p><b>Other methods of glucose monitoring</b> </p> <p>For the following five comparisons, self‐monitoring versus a different type of self‐monitoring (two studies, 43 women); self‐monitoring at home versus hospitalisation (one study, 100 women), pre‐prandial versus post‐prandial glucose monitoring (one study, 61 women), automated telemedicine monitoring versus conventional system (three studies, 84 women), and constant CGM versus intermittent CGM (one study, 25 women), it is uncertain whether any of the interventions has any impact on any of our GRADE outcomes (hypertensive disorders of pregnancy, caesarean section, large‐for‐gestational age) because the quality of the evidence was found to be very low. This was due to evidence largely being derived from single trials, with design limitations and limitations with imprecision (wide CIs, small sample sizes, and few events). There was not enough evidence to assess perinatal mortality and neonatal mortality and morbidity composite. Other important outcomes, such as neurosensory disability, were not reported in any of these comparisons. </p> </section> <section id="CD009613-sec-0007"> <h3 class="title" id="CD009613-sec-0007">Authors' conclusions</h3> <p>Two new studies (406 women) have been incorporated to one of the comparisons for this update. Although the evidence suggests that CGM in comparison to intermittent glucose monitoring may reduce hypertensive disorders of pregnancy, this did not translate into a clear reduction for pre‐eclampsia, and so this result should be viewed with caution. There was no evidence of a difference for other primary outcomes for this comparison. The evidence base for the effectiveness of other monitoring techniques analysed in the other five comparisons is weak and based on mainly single studies with very low‐quality evidence. Additional evidence from large well‐designed randomised trials is required to inform choices of other glucose monitoring techniques and to confirm the effectiveness of CGM. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009613-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009613-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009613-abs-0015">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009613-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009613-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009613-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009613-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009613-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD009613-abs-0007">Português</a> </li> <li class="section-language"> <a class="" href="full/th#CD009613-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009613-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009613-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009613-abs-0005" lang="en"> <h3>Methods for monitoring blood glucose in pregnant women with diabetes to improve outcomes</h3> <p><b>What is the issue and why is this important?</b> </p> <p>If a mother already has diabetes when she becomes pregnant, she and her baby are at higher risk of various problems. Women with existing diabetes that is not well‐controlled at conception and in the first three months of pregnancy are at increased risk of miscarriage, having a baby with developmental problems or stillbirth. The baby is also at increased risk of developing diabetes in childhood. Problems for mothers include developing high blood pressure and associated ill‐health, early births, large babies, difficult births and the need for caesarean section. During labour the baby is at increased risk of a shoulder becoming stuck (shoulder dystocia) and of bleeding in the brain (intracranial haemorrhage). After birth the baby is more likely to have low blood sugar levels (hypoglycaemia), jaundice and breathing problems. This means they are more likely to be admitted to intensive care. During pregnancy, the mother will have her blood glucose (sugar) levels monitored so appropriate steps can be taken to control her blood sugar. </p> <p>Several methods of monitoring blood glucose are used, including regular testing at antenatal clinics and self‐monitoring by women at home. The timing varies, such as monitoring before meals versus monitoring after meals, and how often levels are measured. For continuous glucose monitoring (CGM), technologies are used to transfer information directly from the woman to her clinician and include telemedicine (telephone and video systems, information technology) and digital technologies (mobile phones, tablets). The aim of these methods is to provide a more accurate measure of blood sugar levels so that they can be more effectively controlled, in order to reduce potential problems. </p> <p><b>What evidence did we find?</b> </p> <p>This is an update of a review first published in 2014, updated in 2017. We searched for evidence from randomised controlled studies in November 2018. We identified 12 studies involving 944 women (type 1 diabetes: 660 women; type 2 diabetes: 113 women; in two trials (171 women) there was a mix of type 1 and type 2 diabetes. The trials were from Europe, USA and Canada. </p> <p>There were six comparisons. These were: continuous versus intermittent monitoring of blood glucose (four studies, 609 women); two different ways of self‐monitoring (two studies, 43 women); self‐monitoring at home versus hospitalisation to control blood glucose levels (one study, 100 women); blood glucose monitoring before a meal (pre‐prandial) versus blood glucose monitoring after a meal (post‐prandial) (one study, 61 women); automated telemedicine monitoring versus conventional care (three studies, 84 women); and constant continuous monitoring versus intermittent continuous monitoring (one study, 25 women), </p> <p>Continuous versus intermittent monitoring may reduce overall high blood pressure problems during pregnancy (two studies, 384 women, low‐quality evidence). However, it should be noted that only two of four relevant studies reported data for this outcome. There was more evidence on high blood pressure and protein in their urine (pre‐eclampsia), which showed no clear difference (four studies, 609 women). We also found no difference in the number of women having a caesarean section (three studies, 427 women; moderate‐quality evidence). There was not enough evidence to assess infant deaths or the combined outcome of infant deaths and ill‐health as these outcomes were based on single studies. Four studies received some support from commercial partners. </p> <p>The other comparisons of different ways of monitoring blood glucose levels were based on very small studies or single studies with very low‐quality evidence that did not show any clear differences in outcomes. </p> <p><b>What does this mean?</b> </p> <p>Although the evidence from randomised controlled studies suggests that continuous monitoring of blood glucose levels may be more effective in reducing high blood pressure problems during pregnancy, only two studies reported on this. There was no clear reduction for pre‐eclampsia based on evidence from four studies. For other methods of glucose monitoring, the review showed that there is not enough evidence to say with any certainty which monitoring method for blood glucose is best. More research is needed to find out which other monitoring method is best at reducing the risk of complications for pregnant women with pre‐existing diabetes and to confirm the effectiveness of continuous glucose monitoring. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009613-sec-0143" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009613-sec-0143"></div> <h3 class="title" id="CD009613-sec-0144">Implications for practice</h3> <section id="CD009613-sec-0144"> <p>Two new studies (406 women) have been incorporated to one of the comparisons for this update. Although the evidence suggests that continuous glucose monitoring (CGM) in comparison to intermittent glucose monitoring may reduce hypertensive disorders of pregnancy, this did not translate into a clear reduction for pre‐eclampsia, and so this result should be viewed with caution. There was no evidence of a difference for other primary outcomes for this comparison. The evidence base for the effectiveness of other monitoring techniques analysed in the other five comparisons is weak and based on mainly single studies with very low‐quality evidence. The body of evidence from randomised trials assessing the effects of different techniques of monitoring blood glucose for women with pre‐existing diabetes is therefore incomplete. More trials are needed to confirm the potential benefits of CGM and the effects of other techniques of monitoring in order to inform practice. </p> </section> <h3 class="title" id="CD009613-sec-0145">Implications for research</h3> <section id="CD009613-sec-0145"> <p>More research is needed to identify the most effective techniques of blood glucose monitoring in pregnant women and to confirm the effectiveness of CGM. The current evidence is limited by the small number of randomised controlled trials (RCTs) for most of the comparisons assessed, small sample sizes, and the variable methodological quality of the RCTs. More evidence is needed to assess the effects of different techniques of monitoring blood glucose for women with pre‐existing diabetes on outcomes for mothers and their children, including use and costs of health care, long‐term outcomes and patient‐reported outcomes. Future RCTs may consider collecting and reporting on the standard outcomes suggested in this review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009613-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009613-sec-0036"></div> <div class="table" id="CD009613-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a hospital centre for pregnant women with diabetes in Denmark, 1 study in two secondary care multi‐disciplinary obstetric diabetic clinics in the UK, 1 multi‐centre study in 31 hospital and diabetic clinics in Canada, England, Scotland, Spain, Italy, Ireland and the USA, and 1 multi‐centre study in 22 hospital outpatient obstetric and endocrinology clinics (university, teaching and non‐teaching in the Netherlands and 1 university hospital in Belgium). </p> <p><b>Intervention:</b> continuous glucose monitoring<br/> <b>Comparison:</b> intermittent glucose monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intermittent self‐glucose monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with continuous glucose monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.39 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>384<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>170 per 1000<br/> (114 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.75 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>427<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>564 per 1000<br/> (450 to 708) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.57 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>421<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>546 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>459 per 1000<br/> (311 to 688) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.05 to 12.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (2 to 394) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear risk of allocation concealment and high risk for selective outcome reporting </p> <p><sup>2</sup> We downgraded (1) level for serious indirectness due to the two studies reporting this composite outcome in different ways: <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> reported a composite of pregnancy‐induced hypertension and pre‐eclampsia for women with type 1 diabetes and type 2 diabetes for; and <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> reporting a composite of worsening chronic, gestational and pre‐eclampsia for women with type 1 diabetes </p> <p><sup>3</sup> We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity I<sup>2</sup> = 41% </p> <p><sup>4</sup> We downgraded (1) level for serious imprecision due to wide CI crossing the line of no effect </p> <p><sup>5</sup> We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity I<sup>2</sup> = 70% </p> <p><sup>6</sup> We downgrade (2) levels for very serious imprecision due to evidence derived from a single study, with a small number of events, wide CI crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009613-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring compared to a different type of self‐monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Self‐monitoring compared to standard care for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a high‐risk obstetric clinic at University hospital in the USA<br/> <b>Intervention:</b> self‐monitoring<br/> <b>Comparison:</b> standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with self‐monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.78<br/> (0.40 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>643 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>501 per 1000<br/> (257 to 958) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 67.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the standard care group and so anticipated absolute effects could not be calculated. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in design limitations due unclear allocation concealment and high risk for attrition </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009613-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Self‐monitoring at home compared to hospitalisation for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Self‐monitoring compared to hospitalisation for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in Sweden with monitoring at home or in hospital<br/> <b>Intervention:</b> self‐monitoring<br/> <b>Comparison:</b> hospitalisation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with hospitalisation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with self‐monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19</p> <p>(0.41 to 3.51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> <p>(45 to 381)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.65 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>480 per 1000<br/> (325 to 720) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/> (0.05 to 13.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (1 to 288) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear randomisation, allocation concealment and high risk for attrition </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009613-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a joint metabolic and antenatal clinic in Belfast </p> <p><b>Intervention:</b> pre‐prandial<br/> <b>Comparison:</b> post‐prandial glucose monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with post‐prandial glucose monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pre‐prandial</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this composite outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.45<br/> (0.92 to 2.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>467 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>677 per 1000<br/> (429 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.73 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000<br/> (365 to 925) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.91<br/> (0.12 to 68.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the standard care group and so anticipated absolute effects could not be calculated. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear methods of randomisation and high risk of attrition </p> <p><sup>2</sup> We downgrade (2) levels for very serious limitations in imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009613-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 2 studies in antenatal diabetic clinics in Italy, 1 study in gastroenterology and metabolic diseases clinic in Poland<br/> <b>Intervention:</b> automated telemedicine monitoring<br/> <b>Comparison:</b> conventional monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with automated telemedicine monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this composite outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.62 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>733 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>704 per 1000<br/> (455 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious design limitations due to high risk for randomisation, allocation concealment, attrition and other bias </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009613-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in University clinic of endocrinology, diabetes and metabolic disorders in Macedonia<br/> <b>Intervention:</b> constant CGM<br/> <b>Comparison:</b> intermittent CGM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Intermittent CGM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with constant CGM</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.77<br/> (0.33 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>538 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000<br/> (178 to 964) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in design due to unclear randomisation and allocation concealment </p> <p><sup>2</sup> We downgraded (2) levels for very serious limitations in imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009613-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009613-sec-0037"></div> <section id="CD009613-sec-0038"> <h3 class="title" id="CD009613-sec-0038">Description of the condition</h3> <section id="CD009613-sec-0039"> <h4 class="title">Types of diabetes</h4> <p>There are three main types of diabetes mellitus: type 1, type 2 and gestational diabetes mellitus (GDM). Type 1 or insulin‐dependent diabetes results from the body’s failure to produce sufficient insulin and accounts for a minority of the total burden of diabetes in a population. Type 2 diabetes results from a failure of the body to utilise insulin, causing high blood sugar levels. Type 2 diabetes alone constitutes about 85% to 95% of all diabetes globally (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>). Type 2 diabetes is a serious and growing global health problem that has evolved in association with rapid cultural and social changes, ageing populations, increasing urbanisation, dietary changes, reduced physical activity and other unhealthy lifestyle and behavioural patterns (<a href="./references#CD009613-bbs2-0071" title="WHO . Prevention of diabetes mellitus. Report of a WHO Study Group. Geneva, 1994; Vol. 844:55‐9. ">WHO 1994</a>). In GDM, women who were not previously diabetic develop carbohydrate intolerance resulting in hyperglycaemia (high blood sugar levels) with first onset or detection occurring during pregnancy (<a href="./references#CD009613-bbs2-0032" title="HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. International Journal of Gynecology and Obstetrics2002;78:69‐77. ">HAPO 2002</a>). GDM develops in one in 25 pregnancies worldwide and it is associated with the increasing incidence of type 2 diabetes post‐pregnancy. There are also women who are diagnosed with type 1 or type 2 diabetes before they get pregnant and so have pre‐existing diabetes. This review focuses on women with pre‐existing diabetes. </p> </section> <section id="CD009613-sec-0040"> <h4 class="title">Prevalence of diabetes</h4> <p>Diabetes mellitus is found in every population in the world and it is estimated that 6.6% of the global population in the age group of 20 to 79 years old had diabetes in 2010. By 2030, it is estimated that 7.8% of the adult population will have diabetes (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>). </p> <p>Diabetes mellitus complicates about 2% to 3% of all pregnancies. Approximately 90% of diabetes in pregnancy is accounted for by GDM. Pre‐existing type 1 and type 2 diabetes account for the remaining 10% of diabetes during pregnancy (<a href="./references#CD009613-bbs2-0054" title="MooreTR . Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. American Journal of Obstetrics and Gynecology2010;202:643‐9. ">Moore 2010</a>). This review considers only the care of pregnant women with pre‐existing diabetes. A separate Cochrane Review on GDM has been published (<a href="./references#CD009613-bbs2-0061" title="RamanP , ShepherdE , DowswellT , MiddletonP , CrowtherCA . Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD011069.pub2] ">Raman 2017</a>). </p> </section> <section id="CD009613-sec-0041"> <h4 class="title">Complications of diabetes in pregnancy: for mother and baby</h4> <p>Women with diabetes of any kind are at increased risk of morbidity and mortality during pregnancy.  Pregnancy outcomes for women with pre‐existing diabetes and their infants are poor compared to those for women who do not have diabetes (<a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). The risks to both women and infants include fetal macrosomia (large baby), preterm birth, birth trauma (to mother and infant), induction of labour or caesarean section, miscarriage, congenital malformation, stillbirth, transient neonatal morbidity, neonatal death, obesity or diabetes, or both developing later in the baby’s life (<a href="./references#CD009613-bbs2-0030" title="Gonzalez‐GonzalezNL , RamirezO , MozasJ , MelchorJ , ArmasH , Garcia‐HernandezJA , et al. Factors influencing pregnancy outcome in women with type 2 versus type 1 diabetes mellitus. Acta Obstetricia et Gynecologica Scandinavica2008;87:43‐9. ">Gonzalez‐Gonzalez 2008</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). </p> <p>Women with diabetes have an increased risk of an early miscarriage and are at increased risk of having a baby with malformations. Both of these risks are associated with less than optimal glycaemic control around the time of conception and in the first trimester. The risks appear to be approximately equivalent for women with type 1 and type 2 diabetes. The increased rate of spontaneous miscarriages and fetal malformation appears to be low when glycaemic control is moderately raised, and higher with increasingly poor glycaemic control (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>; <a href="./references#CD009613-bbs2-0037" title="JensenDM , KorsholmL , OvesenP , Beck‐NielsenH , Moelsted‐PedersenL , WestergaardJG , et al. Periconceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care2009;32:1046‐8. ">Jensen 2009</a>). Women with diabetes should be encouraged to obtain the best possible glycaemic control before conception (<a href="./references#CD009613-bbs2-0046" title="KitzmillerJL , WallersteinR , CorreaA , KwanS . Preconception care for women with diabetes and prevention of major congenital malformations. Birth Defects Research. Part A, Clinical and Molecular Teratology2010;88(10):791‐803. ">Kitzmiller 2010</a>). Women with uncontrolled glycaemic levels should be discouraged from becoming pregnant until their blood glucose control can be improved. </p> <p>Macrosomia, defined as infant birthweight greater than 4.5 kg, remains the commonest complication of pregnancy in women with diabetes (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). Macrosomia occurs in 27% to 62% of infants of diabetic mothers compared with 10% of non‐diabetic mothers (<a href="./references#CD009613-bbs2-0028" title="GabbeSG , GravesCR . Management of diabetes mellitus complicating pregnancy. Obstetrics and Gynecology2003;102:857‐68. ">Gabbe 2003</a>). Nationwide studies from the Netherlands, the UK, and Denmark estimate that the risk of a mother with type 1 diabetes giving birth to a baby who is large‐for‐gestational age, or has macrosomia ranges from 48.8% to 62.5% (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). Recent data confirm that women with type 2 diabetes have an equally high risk of giving birth to an infant with macrosomia (<a href="./references#CD009613-bbs2-0019" title="ACOG Committee on Practice Bulletins, authors . Pregestational diabetes mellitus: ACOG Clinical Management Guidelines for Obstetrician‐Gynecologists #60. Obstetrics &amp; Gynecology2005;105:675‐85. ">ACOG 2005</a>; <a href="./references#CD009613-bbs2-0020" title="ADA . Preconception care of women with diabetes (Position Statement). Diabetes Care2004;27:S76‐S78. ">ADA 2004</a>; <a href="./references#CD009613-bbs2-0064" title="RolandJM , MurphyHR , BallV , Northcote‐WrightJ , TempleRC . The pregnancies of women with type 2 diabetes: poor outcomes but opportunities for improvement. Diabetic Medicine2005;22:1774‐7. ">Roland 2005</a>). For mothers with diabetes, macrosomia leads to an increased risk of perineal lacerations, complications in labour, and delivery by caesarean section (<a href="./references#CD009613-bbs2-0067" title="SlocumJ , BarcioL , DaranyJ , FriedleyK , HomkoC , MillsJJ , et al. Preconception to postpartum: management of pregnancy complicated by diabetes. Diabetes Educator2004;30(5):740, 742‐4, 747‐53. ">Slocum 2004</a>). There are increased risks for the infants of intracranial haemorrhage, shoulder dystocia, neonatal hypoglycaemia, jaundice, and respiratory distress (<a href="./references#CD009613-bbs2-0069" title="ThomasAM . Pregnancy with preexisting diabetes. In: MensingC , CypressM , HalstensenC , McLaughlinS , WalkerEA editor(s). Art and Science of Diabetes Self‐Management Education. A Desk Reference for Healthcare Professionals. Chicago: American Association of Diabetic Educators, 2006:233‐57. ">Thomas 2006</a>), as well as the longer‐term health risks of insulin resistance, obesity and type 2 diabetes (<a href="./references#CD009613-bbs2-0050" title="McElduffA , CheungNW , McIntyreHD , LagstromJA , OatsJJ , RossGP , et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy (Position Statement). Medical Journal of Australia2005;183:373‐7. ">McElduff 2005</a>). Overt diabetes is an undisputed factor for preterm birth (<a href="./references#CD009613-bbs2-0066" title="SibaiBM , CaritisSN , HauthJC , MacPhersonC , VanDorstenJP , KlebanoffM , et al. Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. The National institute of Child health and Human Development Maternal‐ Fetal Medicine Units Network. American Journal of Obstetrics and Gynecology2000;183(6):1520‐4. ">Sibai 2000</a>). </p> <p>Fetal hyperglycaemia causes fetal hypoxia and acidosis, which may explain the excess stillbirth rates observed in women with poorly controlled diabetes (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). Infants with macrosomia due to poor maternal glycaemic control and fetal hyperinsulinaemia are more likely to develop obesity and glucose intolerance later in life (<a href="./references#CD009613-bbs2-0026" title="FetitaLS , SobngwiE , SerradasP , CalvoF , GautierJF . Consequences of fetal exposure to maternal diabetes in offspring. Journal of Clinical Endocrinology and Metabolism2006;91:3714‐24. ">Fetita 2006</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). Long‐term (five to 15 years) follow‐up studies of infants of mothers with diabetes suggest that poor glycaemic control during pregnancy has a negative influence on intellectual and psychomotor development (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). Both findings highlight the prolonged effects on offspring of intrauterine exposure to diabetes (<a href="./references#CD009613-bbs2-0026" title="FetitaLS , SobngwiE , SerradasP , CalvoF , GautierJF . Consequences of fetal exposure to maternal diabetes in offspring. Journal of Clinical Endocrinology and Metabolism2006;91:3714‐24. ">Fetita 2006</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). </p> </section> <section id="CD009613-sec-0042"> <h4 class="title">Glycaemic control prior to conception and in early pregnancy</h4> <p>The increased risks in women with diabetes of an early miscarriage and of having a baby with malformations are associated with suboptimal glycaemic control before or around the time of conception, and in the first trimester. Guidelines recommend that women should achieve the best possible glycaemic control before conception: women who improve their glycaemic control before conception have a reduced rate of fetal malformation (<a href="./references#CD009613-bbs2-0027" title="FuhrmannK , ReiherH , SemmlerK , FischerF , FischerM , GlöcknerE . Prevention of congenital malformations in infants of insulin‐dependent diabetic mothers. Diabetes Care1983;6(3):219‐23. ">Fuhrmann 1983</a>; <a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). </p> <p>Maternal hyperglycaemia during the first few weeks of pregnancy is strongly associated with increased spontaneous abortions and major congenital malformations (<a href="./references#CD009613-bbs2-0044" title="KitzmillerJL , BuchananTA , KjosS , CombsCA , RatnerRE . Pre‐conception care of diabetes, congenital malformations and spontaneous abortions (ADATechnical Review). Diabetes Care1996;19:514–41. ">Kitzmiller 1996</a>; <a href="./references#CD009613-bbs2-0062" title="RayJG , O’BrienTE , ChanWS . Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta‐analysis. Quarterly Journal of Medicine2001;94:435‐44. ">Ray 2001</a>). After 12 weeks’ gestation, hyperglycaemia induces fetal hyperinsulinaemia, accelerated growth, and excess adiposity in animal models and in women with diabetes (<a href="./references#CD009613-bbs2-0028" title="GabbeSG , GravesCR . Management of diabetes mellitus complicating pregnancy. Obstetrics and Gynecology2003;102:857‐68. ">Gabbe 2003</a>). These risks appear to be approximately equivalent for women with type 1 and type 2 diabetes. The increased rate of spontaneous miscarriages appears to be low when the HbA1c is modestly raised, and higher with increasingly poor glycaemic control (<a href="./references#CD009613-bbs2-0053" title="MillsJL , SimpsonJL , DriscollSG , Jovanovic‐PetersonL , VanAllenM , AaronsJH , et al. Incidence of spontaneous abortion among normal women and insulin‐dependent diabetic women whose pregnancies were identiﬁed within 21 days of conception. New England Journal of Medicine1988;319(25):1617‐23. ">Mills 1988</a>; <a href="./references#CD009613-bbs2-0065" title="RosennB , MiodovnikM , CombsCA , KhouryJ , SiddiqiTA . Pre‐conception management of insulin‐dependent diabetes: improvement of pregnancy outcome. Obstetrics &amp; Gynecology1991;77(6):846‐9. ">Rosenn 1991</a>). The same pattern is also found with respect to the rate of fetal malformations (<a href="./references#CD009613-bbs2-0031" title="GreeneMF , HareJW , ClohertyJP , BenacerrafBR , SoeldnerJS . First‐trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy. Teratology1989;39(3):225‐31. ">Greene 1989</a>; <a href="./references#CD009613-bbs2-0068" title="SuhonenL , HiilesmaaV , TeramoK . Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia2000;43:79‐82. ">Suhonen 2000</a>). </p> </section> </section> <section id="CD009613-sec-0043"> <h3 class="title" id="CD009613-sec-0043">Description of the intervention</h3> <section id="CD009613-sec-0044"> <h4 class="title">Techniques of blood glucose monitoring</h4> <p>Glucose readings supply trend information that helps to identify and prevent unwanted periods of hypo‐ and hyperglycaemia that are associated with adverse outcomes for both mother and baby. Women with type 1 and type 2 diabetes are advised to self‐monitor their blood glucose throughout pregnancy (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>). </p> <p>Techniques of blood glucose monitoring to be considered in this review include self‐monitoring of blood glucose (SMBG), continuous glucose monitoring (CGM) and clinic monitoring (for which timing and frequency of monitoring are also considered). </p> <p> <ol id="CD009613-list-0001"> <li> <p>Self‐monitoring of blood glucose (SMBG): a glucose meter (glucometer), with or without memory, can be used to measure capillary glucose. Conventional intensified glucose monitoring is deﬁned as three to four blood glucose measurements per day (<a href="./references#CD009613-bbs2-0021" title="American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care2011;34(Suppl 1):S11‐S61. ">ADA 2011</a>). Post‐prandial glucose during pregnancy has been identified as the best  predictor of neonatal  macrosomia (<a href="./references#CD009613-bbs2-0025" title="deVecianaM , MajorCA , MorganMA , AsratT , TooheyJS , LienJM , et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New England Journal of Medicine1995;333(19):1239‐41. ">de Veciana 1995</a>; <a href="./references#CD009613-bbs2-0055" title="Moses RG ,  Lucas EM ,   Knights S . Gestational diabetes mellitus. At what time should the postprandial glucose level be monitored?. Australian and New Zealand Journal Of Obstetrics and Gynaecology1999;39(4):457‐60. ">Moses 1999</a>). Therefore, SMBG protocols for women with type 1 or type 2 diabetes during pregnancy stress the importance of measuring blood glucose after meals (<a href="./references#CD009613-bbs2-0039" title="JovanovičL . Medical Management of Pregnancy Complicated by Diabetes. 4th Edition. Alexandria, VA: American Diabetes Association, 2009. ">Jovanovič 2009</a>), while for non‐pregnant women with diabetes, pre‐prandial values are recommended (<a href="./references#CD009613-bbs2-0021" title="American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care2011;34(Suppl 1):S11‐S61. ">ADA 2011</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). </p> </li> <li> <p>Continuous glucose monitoring (CGM): the continuous glucose monitors currently available measure blood glucose either with minimal invasiveness through continuous measurement of interstitial ﬂuid (ISF) or with the non‐invasive method of applying electromagnetic radiation through the skin to blood vessels in the body. The technologies for bringing a sensor into contact with ISF include inserting an indwelling sensor subcutaneously (into the abdominal wall or arm) to measure ISF in situ or harvesting this ﬂuid by various mechanisms that compromise the skin barrier and delivering the ﬂuid to an external sensor (<a href="./references#CD009613-bbs2-0022" title="CholeauC , KleinJC , ReachG , AussedatB , Demaria‐PesceV , WilsonGS , et al. Calibration of a subcutaneous amperometric glucose sensor. Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current. Biosensors and Bioelectronics2002;17(8):641–6. ">Choleau 2002</a>). After a warm‐up period of up to two hours and a device‐specific calibration process, each device’s sensor provides a blood glucose reading every one to 10 minutes for up to 72 hours with the minimally invasive technology and up to three months with the non‐invasive technology. CGM can provide up to 288 measurements a day (<a href="./references#CD009613-bbs2-0056" title="MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. ">Murphy 2007</a>). </p> </li> <li> <p>Clinic monitoring refers to routine glucose monitoring during antenatal visits either using capillary or whole blood. </p> </li> </ol> </p> </section> <section id="CD009613-sec-0045"> <h4 class="title">Timing and frequency of glucose monitoring</h4> <p>Post‐prandial glucose monitoring has been shown to be able to improve glycaemic control and thus reduce the risk of neonatal hypoglycaemia, macrosomia and caesarean delivery (<a href="./references#CD009613-bbs2-0025" title="deVecianaM , MajorCA , MorganMA , AsratT , TooheyJS , LienJM , et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. New England Journal of Medicine1995;333(19):1239‐41. ">de Veciana 1995</a>), as well as to reduce the incidence of pre‐eclampsia and neonatal triceps skinfold thickness (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>). Post‐prandial glucose values were most strongly associated with increased birthweight in the studies in which both pre‐ and post‐meal glucose were measured (<a href="./references#CD009613-bbs2-0051" title="MelloG , ParrettiE , MecacciF , LaTorreP , CioniR , CianciulliD , et al. What degree of maternal metabolic control in women with type 1 diabetes is associated with normal body size and proportions in full‐term infants?. Diabetes Care2000;23:1494‐8. ">Mello 2000</a>). </p> <p>Pregnant women with diabetes mellitus are advised to test fasting and one‐hour post‐prandial blood glucose levels after every meal during pregnancy and those taking insulin are encouraged to test their blood glucose before going to bed at night (<a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). The American Diabetes Association also recommends SMBG before and after meals and occasionally at night time, to provide optimal results in pregnancy (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). </p> <p>The optimal frequency and timing of home glucose testing during pregnancy is unknown. In reality the frequency of glucose monitoring will depend on women's compliance, with few managing to carry out high numbers of tests daily (<a href="./references#CD009613-bbs2-0042" title="KerssenA , DeValkHW , VisserGH . Do HbA1c levels and the self‐monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus?. Diabetologia2006;49(1):25‐8. ">Kerssen 2006</a>). </p> <p>Educational approaches incorporating additional glucose testing after meals to improve glycaemic control in late gestation have shown potential to reduce birthweight (<a href="./references#CD009613-bbs2-0034" title="HoworkaK , PumprlaJ , GabrielM , FeiksA , SchluscheC , NowotnyC , et al. Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out‐patient education adapted for pregnancy. Diabetic Medicine2001;18(12):965‐72. ">Howorka 2001</a>). </p> </section> <section id="CD009613-sec-0046"> <h4 class="title">Glycaemic control during pregnancy among women with pre‐existing diabetes</h4> <p>Pregnancy profoundly affects the management of diabetes (<a href="./references#CD009613-bbs2-0028" title="GabbeSG , GravesCR . Management of diabetes mellitus complicating pregnancy. Obstetrics and Gynecology2003;102:857‐68. ">Gabbe 2003</a>; <a href="./references#CD009613-bbs2-0038" title="JovanovicL , NakaiY . Successful pregnancy in women with type 1 diabetes: from preconception through postpartum care. Endocrinology and Metabolism Clinics of North America2006;35:79‐97, vi. ">Jovanovic 2006</a>). Pregnancy is associated with changes in insulin sensitivity, which may lead to changes in plasma glucose levels. Hormonal changes during pregnancy cause a progressive increase in insulin resistance, necessitating intensive medical nutrition therapy and frequently adjusted insulin administration throughout the pregnancy. The control of hyperglycaemia in pregnant women with pre‐existing diabetes is essential in order to avoid the above mentioned adverse maternal and infant outcomes (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). Macrosomia and other neonatal complications are minimised with intensified glycaemic control (<a href="./references#CD009613-bbs2-0043" title="KerssenA , DeValkHW , VisserGH . Increased second trimester maternal glucose levels are related to extremely large‐for‐gestational‐age infants in women with type 1 diabetes. Diabetes Care2007;30:1069‐74. ">Kerssen 2007</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>; <a href="./references#CD009613-bbs2-0068" title="SuhonenL , HiilesmaaV , TeramoK . Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia2000;43:79‐82. ">Suhonen 2000</a>).  </p> <p>If it is safely achievable, women with diabetes should aim to keep fasting blood glucose between 3.5 mmol/L and 5.9 mmol/L and one‐hour post‐prandial blood glucose below 7.8 mmol/L during pregnancy (<a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>); HbA1c should be kept below 6.0% (<a href="./references#CD009613-bbs2-0021" title="American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care2011;34(Suppl 1):S11‐S61. ">ADA 2011</a>). Excellent glycaemic control throughout the pregnancy is associated with the lowest risk for both maternal, fetal and neonatal complications (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). On the other hand, the targets of glycaemic control for non‐pregnant women with type 1 or type 2 diabetes are less stringent, i.e. fasting blood glucose to be 3.9 mmol/L to 7.2 mmol/L and HbA1c less than 7.0% (<a href="./references#CD009613-bbs2-0021" title="American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care2011;34(Suppl 1):S11‐S61. ">ADA 2011</a>). </p> </section> </section> <section id="CD009613-sec-0047"> <h3 class="title" id="CD009613-sec-0047">How the intervention might work</h3> <p>Maternal glucose levels in women with pre‐existing diabetes directly influence those of the fetus. Fetal metabolic complications may give rise to macrosomia, congenital malformation, stillbirth and increased perinatal mortality (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>; <a href="./references#CD009613-bbs2-0040" title="KapoorN , SankaranS , HyerS , ShehataH . Diabetes in pregnancy: a review of current evidence. Current Opinion in Obstetrics and Gynecology2007;19:586‐90. ">Kapoor 2007</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; <a href="./references#CD009613-bbs2-0058" title="National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period [NG3]. Available at: https://www.nice.org.uk/guidance/ng3 [Accessed 19 March 2019]2015. ">NICE 2015</a>). Blood glucose monitoring allows adjustment of insulin dosage in relation to meal size and type, physical activity, stress and time of the day for women with pre‐existing diabetes during pregnancy (<a href="./references#CD009613-bbs2-0023" title="DavidsonJ . Strategies for improving glycemic control: effective use of glucose monitoring. American Journal of Medicine2005;118(9 Suppl 1):27–32. ">Davidson 2005</a>). This will limit the maternal risk of hypoglycaemic episodes while avoiding prolonged periods of hyperglycaemia. However, the frequency and timing of glucose monitoring will also influence maternal and fetal outcomes. </p> </section> <section id="CD009613-sec-0048"> <h3 class="title" id="CD009613-sec-0048">Why it is important to do this review</h3> <p>Self‐monitoring of blood glucose is recommended as a key component of diabetes therapy during pregnancy and is included in the management plan (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>; <a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>; <a href="./references#CD009613-bbs2-0057" title="NICE . Diabetes in Pregnancy. Clinical Guideline 63. RCOG Press, 2008. ">NICE 2008</a>; ). No existing systematic reviews consider the benefits of various techniques of blood glucose monitoring on maternal and infant outcomes among pregnant women with pre‐existing diabetes. The effectiveness of the various monitoring techniques is unclear. This systematic review aims to generate information to guide pregnant women with pre‐existing diabetes and their clinicians in their choice of monitoring techniques in order to optimise maternal and infant outcomes. All trials that evaluate any techniques of blood glucose monitoring among pregnant women with pre‐existing diabetes will be considered. This Cochrane Review is an update of a review that was first published in 2014 (<a href="./references#CD009613-bbs2-0073" title="MoyFM , RayA , BuckleyBS . Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2014, Issue 4. [DOI: 10.1002/14651858.CD009613.pub2] ">Moy 2014</a>) and subsequently updated in 2017 (<a href="./references#CD009613-bbs2-0074" title="MoyFM , RayA , BuckleyBS , WestHM . Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2017, Issue 6. [DOI: 10.1002/14651858.CD009613.pub3] ">Moy 2017</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009613-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009613-sec-0049"></div> <p>To compare techniques of blood glucose monitoring and their impact on maternal and infant outcomes among pregnant women with pre‐existing diabetes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009613-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009613-sec-0050"></div> <section id="CD009613-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009613-sec-0052"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials and quasi‐randomised trials. Cluster‐randomised trials were eligible for inclusion but none were identified. Trials using a cross‐over design were not eligible for inclusion. Abstracts were eligible for inclusion if sufficient information was provided to judge the quality and potential for bias of these trials. </p> </section> <section id="CD009613-sec-0053"> <h4 class="title">Types of participants</h4> <p>Pregnant women with pre‐existing diabetes mellitus (type 1 or type 2). Women with gestational diabetes mellitus (GDM) were excluded. </p> </section> <section id="CD009613-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Techniques of blood glucose monitoring including continuous glucose monitoring (CGM), self‐monitoring of blood glucose (SMBG) or clinic monitoring. We also considered the timing and frequency of monitoring. </p> <p>The following comparisons were considered in this update.</p> <p> <ol id="CD009613-list-0002"> <li> <p>Continuous glucose monitoring (CGM) versus intermittent glucose monitoring (i.e. CGM versus standard care) </p> </li> <li> <p>Self‐monitoring of blood glucose (SMBG) versus different type of SMBG</p> </li> <li> <p>SMBG at home versus hospitalisation</p> </li> <li> <p>Pre‐prandial versus post‐prandial glucose monitoring</p> </li> <li> <p>Automated telemedicine monitoring versus conventional system</p> </li> <li> <p>Constant CGM versus intermittent CGM (e.g. use of a glucose monitor 24 hours per day versus use of a monitor 14 days per month) </p> </li> </ol> </p> </section> <section id="CD009613-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>For this update, we used the Cochrane Pregnancy and Childbirth core outcome set for reviews of diabetes in pregnancy, developed by the Cochrane Pregnancy and Childbirth Australasian satellite. </p> <section id="CD009613-sec-0056"> <h5 class="title">Primary outcomes</h5> <section id="CD009613-sec-0057"> <h6 class="title">Mother</h6> <p> <ol id="CD009613-list-0003"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </li> <li> <p>Caesarean section</p> </li> </ol> </p> </section> <section id="CD009613-sec-0058"> <h6 class="title">Neonatal/infant</h6> <p> <ol id="CD009613-list-0004"> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Mortality or morbidity composite (e.g. pregnancy loss (miscarriage, stillbirth, and neonatal death); birth injury; neonatal glycaemia; hyperbilirubinaemia; respiratory distress; and high level neonatal care of more than 24 hours) </p> </li> <li> <p>Neurosensory disability</p> </li> </ol> </p> </section> </section> <section id="CD009613-sec-0059"> <h5 class="title">Secondary outcomes</h5> <section id="CD009613-sec-0060"> <h6 class="title">Mother</h6> <p> <ol id="CD009613-list-0005"> <li> <p>Pre‐eclampsia</p> </li> <li> <p>Pregnancy‐induced hypertension</p> </li> <li> <p>Eclampsia</p> </li> <li> <p>Induction of labour</p> </li> <li> <p>Perineal trauma</p> </li> <li> <p>Placental abruption</p> </li> <li> <p>Postpartum haemorrhage</p> </li> <li> <p>Postpartum infection</p> </li> <li> <p>Weight gain during pregnancy</p> </li> <li> <p>Adherence to the intervention</p> </li> <li> <p>Behaviour changes associated with the intervention</p> </li> <li> <p>Relevant biomarker changes associated with the intervention (e.g. adiponectin, free fatty acids, triglycerides, high‐density lipoproteins, low‐density lipoproteins, insulin) </p> </li> <li> <p>Sense of well‐being and quality of life</p> </li> <li> <p>Views of the intervention</p> </li> <li> <p>Breastfeeding (e.g. at discharge, six weeks postpartum)</p> </li> <li> <p>Use of additional pharmacotherapy</p> </li> <li> <p>Glycaemic control during/end of treatment (as defined by trialists) (e.g. HbA1c, fructosamine, fasting blood glucose, post‐prandial blood glucose) </p> </li> <li> <p>Maternal hypoglycaemia</p> </li> <li> <p>Maternal mortality</p> </li> <li> <p>Miscarriage</p> </li> <li> <p>Instrumental vaginal birth*</p> </li> </ol> </p> </section> <section id="CD009613-sec-0061"> <h6 class="title">Long‐term maternal outcomes</h6> <p> <ol id="CD009613-list-0006"> <li> <p>Postnatal depression</p> </li> <li> <p>Postnatal weight retention or return to pre‐pregnancy weight</p> </li> <li> <p>Body mass index (BMI)</p> </li> <li> <p>GDM in a subsequent pregnancy</p> </li> <li> <p>Type 1 diabetes</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> </ol> </p> </section> <section id="CD009613-sec-0062"> <h6 class="title">Neonatal/infant</h6> <p> <ol id="CD009613-list-0007"> <li> <p>Stillbirth</p> </li> <li> <p>Neonatal mortality</p> </li> <li> <p>Gestational age at birth</p> </li> <li> <p>Preterm birth (less than 37 weeks' gestation and less than 34 weeks' gestation)</p> </li> <li> <p>Apgar score (less than seven at five minutes)</p> </li> <li> <p>Macrosomia</p> </li> <li> <p>Small‐for‐gestational age</p> </li> <li> <p>Birthweight and z‐score</p> </li> <li> <p>Head circumference and z‐score</p> </li> <li> <p>Length and z‐score</p> </li> <li> <p>Ponderal index</p> </li> <li> <p>Adiposity (e.g. BMI, skinfold thickness)</p> </li> <li> <p>Shoulder dystocia</p> </li> <li> <p>Bone fracture</p> </li> <li> <p>Nerve palsy</p> </li> <li> <p>Respiratory distress syndrome</p> </li> <li> <p>Hypoglycaemia (variously defined)</p> </li> <li> <p>Hyperbilirubinaemia</p> </li> <li> <p>Neonatal hypocalcaemia</p> </li> <li> <p>Polycythaemia</p> </li> <li> <p>Relevant biomarker changes associated with the intervention (e.g. cord c peptide, cord insulin) </p> </li> <li> <p>Major and minor anomalies</p> </li> </ol> </p> </section> <section id="CD009613-sec-0063"> <h6 class="title">Later infant and childhood secondary outcomes</h6> <p> <ol id="CD009613-list-0008"> <li> <p>Weight and z‐scores</p> </li> <li> <p>Height and z‐scores</p> </li> <li> <p>Head circumference and z‐scores</p> </li> <li> <p>Adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Blood pressure</p> </li> <li> <p>Type 1 diabetes</p> </li> <li> <p>Type 2 diabetes</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Dyslipidaemia or metabolic syndrome</p> </li> <li> <p>Educational achievement</p> </li> </ol> </p> </section> <section id="CD009613-sec-0064"> <h6 class="title">Child in adulthood</h6> <p> <ol id="CD009613-list-0009"> <li> <p>Weight</p> </li> <li> <p>Height</p> </li> <li> <p>Adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> <li> <p>Type 1 diabetes</p> </li> <li> <p>Type 2 diabetes</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Dyslipidaemia or metabolic syndrome</p> </li> <li> <p>Employment, education and social status/achievement</p> </li> </ol> </p> </section> <section id="CD009613-sec-0065"> <h6 class="title">Health service use</h6> <p> <ol id="CD009613-list-0010"> <li> <p>Number of hospital or health professional visits (e.g. midwife, obstetrician, physician, dietician, diabetic nurse) </p> </li> <li> <p>Number of antenatal visits or admissions</p> </li> <li> <p>Length of antenatal stay</p> </li> <li> <p>Neonatal intensive care unit admission</p> </li> <li> <p>Neonatal intensive care unit length of stay greater than 24 hours*</p> </li> <li> <p>Length of postnatal stay (mother)</p> </li> <li> <p>Length of postnatal stay (baby)</p> </li> <li> <p>Costs to families associated with the management provided</p> </li> <li> <p>Costs associated with the intervention</p> </li> <li> <p>Cost of maternal care</p> </li> <li> <p>Cost of offspring care</p> </li> </ol> </p> </section> <section id="CD009613-sec-0066"> <h6 class="title">Not pre‐specified</h6> <p> <ol id="CD009613-list-0011"> <li> <p>Birth trauma (shoulder dystocia, bone fracture, nerve palsy) (not pre‐specified as a composite) </p> </li> <li> <p>Neonatal glucose at age one hour</p> </li> <li> <p>Transient tachypnoea</p> </li> <li> <p>Diabetic ketoacidosis</p> </li> <li> <p>Feeding difficulties</p> </li> </ol> </p> <p>*Outcomes not pre‐specified in our protocol ‐ see <a href="#CD009613-sec-0157">Differences between protocol and review</a>. </p> </section> </section> </section> </section> <section id="CD009613-sec-0067"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD009613-sec-0068"> <h4 class="title">Electronic searches</h4> <p>For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (1 November 2018). </p> <p>The Register is a database containing over 25,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full current search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this <a href="https://pregnancy.cochrane.org/pregnancy-and-childbirth-groups-trials-register" target="_blank">link</a>. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD009613-list-0012"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD009613-bbs1-0001" title="">Included studies</a>; <a href="./references#CD009613-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD009613-bbs1-0003" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (1 November 2018 using the search methods detailed in <a href="./appendices#CD009613-sec-0149">Appendix 1</a>. </p> </section> <section id="CD009613-sec-0069"> <h4 class="title">Searching other resources</h4> <p>We contacted the author of <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> for additional information (19 March 2019), no reply received to date (26 April 2019). </p> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD009613-sec-0070"> <h3 class="title" id="CD009613-sec-0070">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD009613-bbs2-0074" title="MoyFM , RayA , BuckleyBS , WestHM . Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2017, Issue 6. [DOI: 10.1002/14651858.CD009613.pub3] ">Moy 2017</a>. </p> <p>For this update, the following methods were used for assessing the seven reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD009613-sec-0071"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted a third review author. </p> </section> <section id="CD009613-sec-0072"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data. For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third review author. Data were entered into Review Manager software (<a href="./references#CD009613-bbs2-0063" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details. </p> </section> <section id="CD009613-sec-0073"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009613-bbs2-0033" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD009613-sec-0074"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD009613-list-0013"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0075"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009613-list-0014"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0076"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009613-list-0015"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0077"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD009613-list-0016"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0078"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD009613-list-0017"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0079"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD009613-list-0018"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD009613-sec-0080"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD009613-sec-0081"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009613-bbs2-0033" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD009613-sec-0094">Sensitivity analysis</a>. </p> </section> <section id="CD009613-sec-0082"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update we assessed the quality of the evidence using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the following outcomes for all comparisons. </p> <p> <ol id="CD009613-list-0019"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD009613-bbs2-0063" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD009613-sec-0083"> <h4 class="title">Measures of treatment effect</h4> <section id="CD009613-sec-0084"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD009613-sec-0085"> <h5 class="title">Continuous data</h5> <p>We used the mean difference if outcomes were measured in the same way between trials. In future updates, if appropriate, we will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD009613-sec-0086"> <h4 class="title">Unit of analysis issues</h4> <section id="CD009613-sec-0087"> <h5 class="title">Trials with more than two intervention groups</h5> <p>Had we included trials with more than two techniques of glucose monitoring, we planned to analyse them according to the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009613-bbs2-0033" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>); the relevant pair of interventions would have been selected and the others excluded. </p> </section> <section id="CD009613-sec-0088"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials for inclusion. However, in future updates, if we identify any cluster‐randomised trials we will include them in the analyses along with individually‐randomised trials. We will adjust their sample sizes using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster‐randomised trials and individually‐randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit. </p> </section> </section> <section id="CD009613-sec-0089"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, levels of attrition were noted. In future updates, if more eligible studies are included, the impact of including studies with high levels of missing data in the overall assessment of treatment effect will be explored by using sensitivity analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD009613-sec-0090"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. Had we identified substantial heterogeneity (above 30%), we planned to explore it by pre‐specified subgroup analysis. </p> </section> <section id="CD009613-sec-0091"> <h4 class="title">Assessment of reporting biases</h4> <p>In future updates, if there are 10 or more studies in the meta‐analysis we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD009613-sec-0092"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD009613-bbs2-0063" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average of the range of possible treatment effects and we discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. Where we used random‐effects analyses, the results are presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD009613-sec-0093"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Had we identified substantial heterogeneity, we planned to investigate it using subgroup analyses and to consider whether an overall summary was meaningful, and if it was, to use a random‐effects analysis to produce it. </p> <p>We planned to restrict subgroup analyses to primary outcomes for the following subgroups:</p> <p> <ol id="CD009613-list-0020"> <li> <p>types of diabetes mellitus (type 1 versus type 2 diabetes);</p> </li> <li> <p>glycaemic control prior to pregnancy (pre‐pregnancy HbA1c within target range versus pre‐pregnancy HbA1c out of target range). </p> </li> </ol> </p> <p>However, we did not carry out any subgroup analysis as there were too few trials included in any one comparison. Data for outcomes in included trials were also not reported separately by type of diabetes. Pre‐pregnancy glycaemic control for all women was comparable at baseline. These analyses will be conducted in future updates of the review, if more data become available. </p> </section> <section id="CD009613-sec-0094"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to undertake sensitivity analysis to explore differences between fixed‐effect or random‐effects analyses for outcomes with statistical heterogeneity. </p> <p>We also planned to undertake sensitivity analysis to assess the effect on pooled results of studies considered to have a high risk of bias. </p> <p>However, due to the scarcity of data in any one comparison, no sensitivity analyses were conducted. If more data become available, the planned sensitivity analyses will be carried out in future updates. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009613-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009613-sec-0095"></div> <section id="CD009613-sec-0096"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD009613-sec-0165" title="">Characteristics of included studies</a>; <a href="./references#CD009613-sec-0166" title="">Characteristics of excluded studies</a>. </p> <section id="CD009613-sec-0097"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD009613-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009613-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram 2018" data-id="CD009613-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram 2018</p> </div> </div> </div> <p>For this 2018 update, we identified 149 trial reports to assess and 113 in total after duplicates had been removed. One‐hundred and six reports were screened out because they did not meet the scope for this review or were not randomised controlled trials. We then assessed seven trial reports for inclusion. We also reassessed the two ongoing studies listed in the previous version of the review (five reports). </p> <p>We included two new trials (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>) (three reports), added one trial report to an already included study (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>), and added one trial report to an already excluded study (<a href="./references#CD009613-bbs2-0013" title="BartholomewLM , SoulesK , ChurchK , ShahaS , BurlingameJ , GrahamG , et al. Managing diabetes in pregnancy using cell phone/internet technology. Clinical Diabetes2015;33(4):169‐74. BartholomewML , ChurchK , GrahamG , BurlingameJ , ZaludI , SauvageL , et al. Managing diabetes in pregnancy using cell phone/internet technology. American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S113‐S114. NCT01907516 . Managing diabetes in pregnancy using cell phone/internet technology. clinicaltrials.gov/show/NCT01907516 Date first received: 22 July 2013. ">Bartholomew 2011</a>). No new studies were excluded in this update. Two trials (two reports) are ongoing (<a href="./references#CD009613-bbs2-0017" title="LinkH , NCT03504592 . Utilizing mHealth to improve diabetes in an obstetric population. https://clinicaltrials.gov/ct2/show/NCT03504592 (first received 20 April 2018). ">Link 2018</a>; <a href="./references#CD009613-bbs2-0018" title="LoganAG , NCT01474525 . Managing diabetes during pregnancy in the wireless age: a RCT of glucose telemonitoring. https://clinicaltrials.gov/ct2/show/NCT01474525 (first received 18 November 2011). ">Logan 2011</a>), see <a href="./references#CD009613-bbs1-0003" title="">Ongoing studies</a>. The two studies previously listed in ongoing were additional reports of the newly included studies (five reports). </p> </section> <section id="CD009613-sec-0098"> <h4 class="title">Included studies</h4> <p>Altogether, this review now comprises 12 included studies (944 women), all of which contributed data. Three of the 12 included trials were from the UK (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>), two were from Italy (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>), and one each was from Sweden (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>), Denmark (<a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>), Macedonia (<a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>), Poland (<a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), the US (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), Canada (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>) and the Netherlands (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>). </p> <p>For full details, see <a href="./references#CD009613-sec-0165" title="">Characteristics of included studies</a>. </p> <section id="CD009613-sec-0099"> <h5 class="title">Methods</h5> <p>All included studies were parallel group randomised controlled trials and involved two arms. The randomisation method was not always well described and in one study the allocation process was not truly random, and so was assessed as being 'quasi‐randomised' (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>). All of the studies were described as being 'open‐label' and therefore not blinded. Two studies were multi‐centre trials: one was based in Canada and involved 31 hospitals in Canada, England, Scotland, Spain, Italy, Ireland and the USA (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>); and one involved 22 hospitals, university, teaching and non‐teaching hospitals in the Netherlands and one university hospital in Belgium (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>). The remaining trials were single centre (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>). </p> </section> <section id="CD009613-sec-0100"> <h5 class="title">Trial dates</h5> <p>Trial dates were not reported in the study reports for six trials (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>). </p> <p>For the remaining studies, trials dates were reported as follows: 25 March 2013 to 22 March 2016 (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>); 1 October 1979 to 1 October 1982 (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>); September 2003 to 2006 (<a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>); 15 February 2009 to 15 February 2011 (<a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>); 1 February 1980 to 16 September 1981 (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>); and July 2011 to September 2015 (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>). </p> </section> <section id="CD009613-sec-0101"> <h5 class="title">Participants</h5> <p>The trials included in this review involved a total of 944 women; 660 with type 1 diabetes, 113 with type 2 diabetes, and 171 women with either type 1 or type 2 diabetes (data not reported separately). </p> <p><a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>, <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a> and <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a> included women with pre‐existing type 1 and type 2 diabetes (however, only <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a> presented the results separately for type 1 and type 2 diabetes). Only women with pre‐existing type 1 diabetes were eligible to participate in <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a><a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>, <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003,</a><a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011,</a><a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980,</a><a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>, and <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>. In one trial (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>), they ran two trials in parallel for pregnant women and for women planning a pregnancy with type 1 diabetes. However the results for most outcomes were reported separately and so we have included the data for the pregnant women in this review. Women with pre‐existing type 1 diabetes and gestational diabetes participated in <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>, however the results are presented separately so only data for women with type 1 diabetes are included in this review. Women with pre‐existing type 1 and type 2 diabetes and gestational diabetes participated in <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>, however the results are presented separately for some of the outcomes, so only data for women with type 1 and type 2 diabetes are included in this review. The ethnicity of the women was not mentioned in all trials. As these trials originated from the European countries and the USA, it is assumed that majority of the women were white or Caucasians. </p> </section> <section id="CD009613-sec-0102"> <h5 class="title">Interventions and comparisons</h5> <p>Continuous glucose monitoring (CGM) was compared with intermittent glucose monitoring in trials by <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>, <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>, <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a> and <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>. <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a> and <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a> compared self‐monitoring of blood glucose (SMBG) at home with standard care. In <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a> the SMBG group measured blood glucose with a glucometer seven times a day, twice weekly and the standard care group (non‐meter group) checked urine glucose four times daily, with random blood glucose measured at fortnightly clinic visits. In <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>, the SMBG group carried out daily home glucose monitoring four times daily and the standard care group carried out weekly venipuncture three times daily, measured on one day weekly. <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a> compared self‐monitoring blood glucose at home from the 32nd week until the 36th week of gestation, with weekly hospital visits, and hospitalisation during the 37th week to delivery with a group who were hospitalised from 32nd week until delivery. <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a> compared timing of glucose monitoring, i.e. pre‐prandial versus post‐prandial. Pre‐prandial refers to measurement of blood glucose before meals while post‐prandial refers to blood glucose measured two hours after a meal. Automated telemedicine monitoring versus conventional system were compared in studies by <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>, <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a> and <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>. Automated telemedicine monitoring refers to automated transmission of blood glucose values via telephone or Internet to the physicians, which allows immediate attention from the physicians. <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a> compared constant CGM with intermittent CGM. CGM refers to glucose measured in subcutaneous tissues every 10 seconds and an average value is stored every five minutes, providing up to 288 measurements per day. </p> </section> <section id="CD009613-sec-0103"> <h5 class="title">Outcomes</h5> <p>The primary outcome composite outcome, hypertensive disorders of pregnancy was reported by <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> (including pre‐eclampsia, pregnancy‐induced hypertension and worsening chronic hypertension), and by <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> (pre‐eclampsia and pregnancy‐induced hypertension); caesarean section was reported by <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; large‐for‐gestational age was reported by <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008;</a><a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>, (defined as birthweight 90th centile or above); perinatal mortality was reported by <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008;</a><a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>); neonatal mortality or morbidity composite was reported by <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; and neurosensory disability was not reported by any trials. </p> <p>Secondary maternal outcomes reported by the included studies were pre‐eclampsia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008;</a><a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), pregnancy‐induced hypertension (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), placental abruption (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>), weight gain during pregnancy (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003;</a><a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>), behaviour changes associated with the intervention (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> (using hypoglycaemia fear survey (HFS II) behaviour subscale which measures two distinct aspects of behavioural avoidance to prevent hypoglycaemia), sense of well‐being and quality of life (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> (using three different questionnaires (blood glucose monitoring system rating questionnaire (BGMSRQ), problem areas in diabetes (PAID), short‐form‐12)), use of additional pharmacotherapy (use of additional insulin therapy: <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; insulin dose: <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003;</a><a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>), glycaemic control during/end of treatment (HbA1c) (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983;</a><a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), maternal hypoglycaemia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>) and miscarriage (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013;</a><a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>). </p> <p>Secondary perinatal/neonatal outcomes reported by the included studies were stillbirth (reported by <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), neonatal mortality (<a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), gestational age at birth (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), preterm birth less than 37 weeks' gestation (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>), preterm birth less than 34 weeks' gestation (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>;) macrosomia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>: defined as birthweight greater than 4 kg in four studies and birthweight above 90th centile in two studies), small‐for‐gestational age (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>: defined as birthweight 10th centile or below), birthweight (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), head circumference (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>), length (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>), adiposity (sum of four skin folds (triceps, subscapular, biceps, flank: <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> ) and (triceps skinfold thickness and subscapular skinfold thickness: <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), shoulder dystocia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>), respiratory distress syndrome (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>, <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), hypoglycaemia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), hyperbilirubinaemia (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), neonatal hypocalcaemia (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), polycythaemia (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), relevant biomarker changes associated with the intervention (neonatal cord vein c‐peptide: <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983,</a> (cord IGF‐1: <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), and major anomalies (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>). </p> <p>The only secondary health service use outcomes reported were antenatal hospital admission (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>), neonatal intensive care (NICU) admissions (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>) and NICU length of admission &gt; 24 hours (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>). </p> <p>Outcomes that were not pre‐specified, but are reported in this review are maternal diabetic ketoacidosis (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>), birth trauma (shoulder dystocia, bone fracture and nerve palsy, pre‐specified as individual outcomes but reported as a composite: <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), neonatal glucose at age one hour (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), transient tachypnoea (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), and feeding difficulties (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>). Instrumental vaginal birth was reported in one trial (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), but the data were not presented separately for women with pre‐existing diabetes and women with GDM. No other trial reported on instrumental vaginal birth. </p> <p>Secondary maternal outcomes not reported by any of the included studies were: induction of labour, perineal trauma, postpartum haemorrhage, postpartum infection, adherence to the intervention, relevant biomarker changes associated with the intervention (e.g. adiponectin, free fatty acids, triglycerides, high‐density lipoproteins, low‐density lipoproteins, insulin), views of the intervention, maternal mortality. </p> <p>Secondary perinatal/neonatal outcomes not reported by any of the included studies were: Apgar score (less than seven at five minutes), head circumference and z‐score, length and z‐score, ponderal index, adiposity measured by body mass index (BMI), and minor anomalies. </p> <p>Health service use outcomes not reported by any of the included studies were: health service use, number of hospital or health professional visits (e.g. midwife, obstetrician, physician, dietician, diabetic nurse), number of antenatal visits, length of antenatal stay, length of postnatal stay (mother), length of postnatal stay (baby), costs to families associated with the management provided, costs associated with the intervention, cost of maternal care, and cost of offspring care. </p> <p>No studies reported long‐term maternal outcomes (postnatal depression, postnatal weight retention or return to pre‐pregnancy weight, BMI, impaired glucose tolerance, cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome)), later infant or childhood outcomes (weight and z‐scores, height and z‐scores, head circumference and z‐scores, adiposity (e.g. as measured by BMI, skinfold thickness), blood pressure, type 1 diabetes, type 2 diabetes, impaired glucose tolerance, dyslipidaemia or metabolic syndrome, educational achievement), or child in adulthood outcomes (weight, height, adiposity (e.g. as measured by BMI, skinfold thickness), cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome), type 1 diabetes, type 2 diabetes, impaired glucose tolerance, dyslipidaemia or metabolic syndrome, employment, education and social status/achievement). </p> <p>Some outcomes were reported in a form that could not be used in this review. <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a> reported the median antenatal hospital stay and neonatal hospital stay, but did not report the standard deviation of blood glucose values, and only reported HbA1c graphically. <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a> reported the median and interquartile range for cord insulin and length of stay in neonatal unit, and <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a> reported weight gain in pregnancy, HbA1c, plasma glucose, gestational age at birth, and birthweight as median and range. Where results were reported as medians, we felt it was unlikely that the results were normally distributed, and excluded them from meta‐analyses. Percentage of maternal hypoglycaemic episodes was reported by <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>, however the total of all blood glucose data was not available, therefore the frequency was not estimable. <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> reported the median and interquartile range for the following outcomes, weight gain during pregnancy, postnatal weight retention or return to pre‐pregnancy weight, gestational age at birth and length of antenatal stay. <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> reported on many of the outcomes of this review (see <a href="./references#CD009613-sec-0165" title="">Characteristics of included studies</a>), but did not report these separately for pre‐gestational and gestational diabetes (we have written to authors requesting separate data for the pre‐gestational diabetes group of women). </p> </section> <section id="CD009613-sec-0104"> <h5 class="title">Sources of trial funding</h5> <p>Sources of trial funding were not reported in two trials (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>). </p> <p>In <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>, the trial was funded by the Juvenile Diabetes Research Foundation (JDRF) and grants under the JDRF Canadian Clinical Trial Network, a public‐private partnership. Metronic supplied the CGM sensors and CGM systems at reduced cost. In <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>, the source of funding was reported as being Expressens Perinatal forskningsfond, AIImanna Barnbordshusets Minnesfond, Svenska Diabetesstiftelsen, Nordisk Insulinfond, Swedish Medical Research Council (Project No. 3787), and Tielman's Fund for Pediatric Research. The Department of Health and Social Sevices, Northern lreland, the Northern Ireland Mother and Baby Appeal, the Metabolic Unit Research Fund, Royal Victoria Hospital Belfast, the Royal Maternity Hospital, and the Irish Perinatal Society funded the trial by <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>. <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a> was an investigator‐initiated study funded by the Ipswich Diabetes Centre Charity Research Fund. The study equipment (six CGMS Gold monitors and 300 sensors) was donated free of charge by Medtronic UK. The research was sponsored by Ipswich Hospital NHS Trust and was independent of all the study funders (<a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>). The Macedonion Ministry of Health and the Health Care Fund of Macedonia funded <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>. In <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>, one of the authors received financial support from the European Foundation of the Study of Diabetes and LifeScan, Rigshopitalet's Research Foundation, the Capital Region of Denmark, the Medical Facuty Foundation of Copenhagen University, Aase and Ejnar Danielsen Foundation, and Master Joiner Sophus Jacobsen and his wife Astrid Jacobsens' Foundation. <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a> was funded by the Medical Research Council Project Grant and the British Diabetic Association. <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a> was funded by a Research Fellowship from the Iowa Affiliate of the American Diabetes Association. <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> was funded by ZonMw, The Dutch Organization for Health Research and Development .Continuous glucose monitors were purchased at a discounted price from Medtronic® and were reported as having no role in the study design, data collection, data analysis, data interpretation, or writing of the report. <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> was supported by grants from the Polish State Committee for Scientific Research, the Bayer Diagnostic Division Warsaw, and the Polish Cellular Telephony Centertel. </p> </section> <section id="CD009613-sec-0105"> <h5 class="title">Trial authors' declarations of interest</h5> <p>Trial authors' declarations of interest were not reported in <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>. </p> <p>In <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>, two trial authors received honorariums for speaking at research symposiums sponsored by Medtronic in 2004 and 2005. In <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>, eight authors report grants from the Juvenile Diabetes Research Foundation during the conduct of the study. Two authors report personal fees from Novo Nordisk, Roche and Medtronic, outside the submitted work. One author reports personal fees from Abbott Diabetes Care and Medtronic (MiniMed Academia), outside the submitted work. One author sits on the Medtronic European Scientific Advisory Board. All remaining authors declare no competing interests. The authors declared that they had no competing financial interests in <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a> and in <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>, other than those reported under 'funding' interests. In <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>, one of the trial authors received a research grant from ZonMW (the Netherlands Organization for Health Research and Development) and a second author received research grants from Abbott, Dexcom, Medtronic and Sensonics, and also received personal fees from Roche Diabetes Care and Sensonics. A third author is supported by an NHMRC Practitioner Fellowshop (GNT1082548) and reports consultancy for ObsEVa, Merck and Guerbet. All other authors declare no support from any organization or conflict of interest. </p> <p>See the <a href="./references#CD009613-sec-0165" title="">Characteristics of included studies</a> table for more details. </p> </section> </section> <section id="CD009613-sec-0106"> <h4 class="title">Excluded studies</h4> <p>No new trials were excluded in this update (2019), but one trial report was identified relating to an already excluded study (<a href="./references#CD009613-bbs2-0013" title="BartholomewLM , SoulesK , ChurchK , ShahaS , BurlingameJ , GrahamG , et al. Managing diabetes in pregnancy using cell phone/internet technology. Clinical Diabetes2015;33(4):169‐74. BartholomewML , ChurchK , GrahamG , BurlingameJ , ZaludI , SauvageL , et al. Managing diabetes in pregnancy using cell phone/internet technology. American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S113‐S114. NCT01907516 . Managing diabetes in pregnancy using cell phone/internet technology. clinicaltrials.gov/show/NCT01907516 Date first received: 22 July 2013. ">Bartholomew 2011</a>). </p> <p><a href="./references#CD009613-bbs2-0013" title="BartholomewLM , SoulesK , ChurchK , ShahaS , BurlingameJ , GrahamG , et al. Managing diabetes in pregnancy using cell phone/internet technology. Clinical Diabetes2015;33(4):169‐74. BartholomewML , ChurchK , GrahamG , BurlingameJ , ZaludI , SauvageL , et al. Managing diabetes in pregnancy using cell phone/internet technology. American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S113‐S114. NCT01907516 . Managing diabetes in pregnancy using cell phone/internet technology. clinicaltrials.gov/show/NCT01907516 Date first received: 22 July 2013. ">Bartholomew 2011</a> was excluded as it is a cross‐over trial. Two trial registrations (<a href="./references#CD009613-bbs2-0014" title="NCT01630759 . Remote monitoring of diabetes in pregnancy: a feasibility study for a randomised controlled trial. clinicaltrials.gov/show/NCT01630759 Date first received: 22 June 2012. ">NCT01630759</a>; <a href="./references#CD009613-bbs2-0016" title="WalkerJD . Blood glucose monitoring strategies in diabetic: an audit of achievement of glycaemic goals and outcome of pregnancy. National Research Register (www.nrr.nhs.uk)1999. ">Walker 1999</a>) were excluded; the former was a trial on women with gestational diabetes mellitus (GDM) while the latter was a clinical trial registration containing insufficient evidence to assess. We contacted the author, but there were no available data or published reports. <a href="./references#CD009613-bbs2-0015" title="TempleRC , DuffieldK , LewisK , MurphyHR . Glycaemic control during pregnancy in women with long duration type 1 diabetes: lessons learn using continuous glucose monitoring systems. Diabetologia2006;49(Suppl 1):S78. ">Temple 2006</a> was excluded as it was an abstract on an observational study of eight pregnant women with type 1 diabetes using continuous glucose monitoring system (CGMS). </p> <p>See the <a href="./references#CD009613-sec-0166" title="">Characteristics of excluded studies</a> table for more details. </p> </section> </section> <section id="CD009613-sec-0107"> <h3 class="title">Risk of bias in included studies</h3> <p>Three of the 12 included studies were at low risk of bias (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>), eight studies were at moderate risk of bias (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), and one study was at high risk of bias (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>). See <a href="#CD009613-fig-0002">Figure 2</a> and <a href="#CD009613-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009613-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009613-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009613-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009613-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009613-sec-0108"> <h4 class="title">Allocation</h4> <section id="CD009613-sec-0109"> <h5 class="title">Random sequence generation</h5> <p>Five studies (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>) described the random sequence generation using computer‐generated random numbers or a random number sequence (low risk of bias). Six trials (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>) did not report how the sequence was generated (unclear risk of bias). One study was quasi‐randomised, allocating women to alternating groups (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>) (high risk of bias). </p> </section> <section id="CD009613-sec-0110"> <h5 class="title">Allocation concealment</h5> <p>Adequate and secure concealment of allocation was described in four trials (low risk of bias) (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>); in one trial the randomisation schedule was created remotely by a programme manager, encrypted, and maintained in a secure database, with no access from the research team (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>), sealed envelopes were used in two of the trials (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>), while the fourth (<a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>) used an automated telephone allocation service (Paravox) provided by an independent organisation. There was no concealment of allocation in <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> and <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a> (high risk of bias). The other trials only mentioned the participants were randomly allocated into intervention or control groups without describing if there was any concealment of allocation (unclear risk of bias). </p> </section> </section> <section id="CD009613-sec-0111"> <h4 class="title">Blinding</h4> <section id="CD009613-sec-0112"> <h5 class="title">Blinding of participants and personnel</h5> <p>As different techniques or timing of glucose monitoring were compared, blinding of neither participants nor assessors was feasible. However, since outcome measures were objective it is unlikely that lack of blinding introduced a risk of bias and so all studies were assessed as being at low risk. </p> </section> <section id="CD009613-sec-0113"> <h5 class="title">Blinding of outcome assessors</h5> <p>As different techniques or timing of glucose monitoring were compared, blinding of neither participants nor assessors was feasible. However, since outcome measures were objective it is unlikely that lack of blinding introduced a risk of bias so all studies were assessed as being at low risk. </p> </section> </section> <section id="CD009613-sec-0114"> <h4 class="title">Incomplete outcome data</h4> <p>Four trials had high risk of bias for incomplete outcome data. Reasons given for attrition were women not completing the questionnaire (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>), severe drug addiction, spontaneous abortions and death of mother (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>), no results for analysis participants (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>) and spontaneous miscarriage (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>). In other included studies, all women were accounted for in the analysis, or rates of attrition were described (low risk of bias). <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>and <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> reported all outcome data. Four trials reported using intention‐to‐treat analysis (<a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>). One trial was assessed as being at unclear risk of bias (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), because there were a high number of women refused to continue using CGM after the first or second time. </p> </section> <section id="CD009613-sec-0115"> <h4 class="title">Selective reporting</h4> <p>It was unclear if there was any selective reporting in one trial (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>),10 trials reported all expected outcome data (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>) (low risk of bias). One trial (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>) was assessed as being at high risk of bias because there were a number of maternal outcomes that were described in the methods of the full report and the protocol, but were not reported in the results section. </p> </section> <section id="CD009613-sec-0116"> <h4 class="title">Other potential sources of bias</h4> <p>There were no other obvious potential sources of bias with the exception of <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a> and <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>. <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a> did not use an intention‐to‐treat analysis, and there was no sample size calculation, or information on whether groups were comparable at baseline (high risk of bias). In <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>, we had some concerns over missing outcomes and were unsure of the impact of this, (unclear risk of bias). </p> </section> </section> <section id="CD009613-sec-0117"> <h3 class="title" id="CD009613-sec-0117">Effects of interventions</h3> <p>See: <a href="./full#CD009613-tbl-0001"><b>Summary of findings for the main comparison</b> Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</a>; <a href="./full#CD009613-tbl-0002"><b>Summary of findings 2</b> Self‐monitoring compared to a different type of self‐monitoring for women with pre‐existing diabetes</a>; <a href="./full#CD009613-tbl-0003"><b>Summary of findings 3</b> Self‐monitoring at home compared to hospitalisation for women with pre‐existing diabetes</a>; <a href="./full#CD009613-tbl-0004"><b>Summary of findings 4</b> Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</a>; <a href="./full#CD009613-tbl-0005"><b>Summary of findings 5</b> Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</a>; <a href="./full#CD009613-tbl-0006"><b>Summary of findings 6</b> Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</a> </p> <p>As there were various methods of glucose monitoring being implemented in the included trials, we structured the review using the following comparisons. </p> <p> <ol id="CD009613-list-0021"> <li> <p>Continuous glucose monitoring (CGM) versus intermittent glucose monitoring</p> </li> <li> <p>Self‐monitoring versus different types of self‐monitoring</p> </li> <li> <p>Self‐monitoring at home versus hospitalisation</p> </li> <li> <p>Pre‐prandial versus post‐prandial glucose monitoring</p> </li> <li> <p>Automated telemedicine monitoring versus conventional system</p> </li> <li> <p>Constant CGM versus intermittent CGM</p> </li> </ol> </p> <section id="CD009613-sec-0118"> <h4 class="title">Comparison 1 ‐ Continuous glucose monitoring (CGM) versus intermittent glucose monitoring</h4> <p>See <a href="./full#CD009613-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>Four studies compared CGM versus intermittent blood glucose monitoring (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>). The total number of women was 609, 384 type 1 diabetes (T1DM) and 191 with type 2 diabetes (T2DM). <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> contributed the largest number of women in this comparison (n = 215), all T1DM. </p> <p><a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> used a CGM system to measure blood glucose. Women were trained to use the study devices and instructed to use them daily by local diabetes or antenatal clinic teams. CGM users were advised to verify the accuracy of their CGM measurements using their capillary glucose meter before insulin dose adjustment (n = 108). Women in the control group continued their usual method of capillary glucose monitoring (n = 107). Women in both groups were advised to test capillary blood glucose levels at least seven times daily and given written instructions for how to use capillary or CGM measures for insulin dose adjustment. <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> randomised both pregnant (n = 215) and women planning pregnancy (n = 110), but reported the results separately for the two cohorts. We have only included the data for the pregnant women in this review. </p> <p><a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> randomised 300 pregnant women with T1DM (n = 109) and T2DM (n = 82), or with gestational diabetes (n = 109). We have only included the data for the women with T1DM and T2DM. However, many of our review outcomes were not reported separately, but mixed with the gestational diabetes cohort and so we have been unable to include all of the data. The CGM group had continuous glucose monitoring in addition to standard care. Women allocated to CGM were instructed to use the device for five to seven days every six weeks and glucose profiles were obtained retrospectively, directly after each use and evaluated by the local endocrinologist. Self‐monitoring of blood glucose (SMBG) was required for calibration of CGM. Readings from the CGM were uploaded to a web‐based program (n = 147 all women, 90 with T1DM and T2DM). Standard treatment consisted of self‐monitoring of blood glucose only (n = 153 all women, 97 with T1DM and T2DM). Women in both intervention and control groups performed SMBG (four to eight times/day: at least fasting, after every meal, at bedtime and, preferably before every meal). </p> <p><a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a> used the CGM, which measured glucose in subcutaneous tissues every 10 seconds and an average value is stored every five minutes, providing up to 288 measurements per day (n = 38). The women were required to wear the CGM for seven days at intervals of four to six weeks. They were also advised to measure blood glucose at least seven times a day. The intermittent monitoring of glucose levels was the standard care in which women were advised to monitor glucose at least seven times a day (n = 33). </p> <p>In <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>, real time CGM for six days at pregnancy visits during eight, 12, 21, 27 and 33 weeks, in addition to routine pregnancy care was implemented on 79 women and intermittent monitoring with self‐monitored plasma glucose measurements of seven times daily was implemented on 75 women. </p> <section id="CD009613-sec-0119"> <h5 class="title">Primary outcomes</h5> <p>Continuous glucose monitoring may reduce the composite outcome of hypertensive disorders of pregnancy (risk ratio (RR) 0.58, 95% confidence interval (CI) 0.39 to 0.84; 2 studies, 384 women; low‐quality evidence<i>,</i><a href="./references#CD009613-fig-0004" title="">Analysis 1.1</a>), although this did not translate into a clear reduction for pre‐eclampsia<b>,</b> see secondary outcomes below. </p> <p>Due to moderate heterogeneity, we used random‐effects analysis for caesarean section and there was no clear reduction in rate of caesarean section (average RR 0.94, 95% CI 0.75 to 1.18; 3 studies, 427 women; I<sup>2</sup> = 41%; moderate‐quality evidence, <a href="./references#CD009613-fig-0005" title="">Analysis 1.2</a>), or large‐for‐gestational age (average RR 0.84, 95% CI 0.57 to 1.26; 3 studies, 421 women; I<sup>2</sup> = 70%; low‐quality evidence, <a href="./references#CD009613-fig-0006" title="">Analysis 1.3</a>)<i>.</i> There was not enough evidence to assess perinatal mortality (RR 0.82, 95% CI 0.05 to 12.61, 71 infants, 1 study, <a href="./references#CD009613-fig-0007" title="">Analysis 1.4</a>, low‐quality evidence<i>)</i> or the composite of neonatal mortality or morbidity (RR 0.80, 95% CI 0.61 to 1.06; 1 study, 200 women) as the evidence was based on single studies of low‐quality. </p> <p><b>Neurosensory disability</b><br/> This outcome was not reported. </p> </section> <section id="CD009613-sec-0120"> <h5 class="title">Secondary outcomes</h5> <p>There was no clear reduction in pre‐eclampsia (RR 0.65, 95% CI 0.39 to 1.08; 4 studies, 609 women; moderate‐quality evidence<i>,</i><a href="https://archie.cochrane.org/sections/documents/view?version=z1904301856449155142356526836087%26format=REVMAN_GRAPHS#CMP-001.06" target="_blank">Analysis 1.6</a>) or to pregnancy‐induced hypertension (RR 0.67, 95% CI 0.38 to 1.16; 2 studies, 384 women; low‐quality evidence<i>,</i><a href="https://archie.cochrane.org/sections/documents/view?version=z1904301856449155142356526836087%26format=REVMAN_GRAPHS#CMP-001.07" target="_blank">Analysis 1.7</a>) with CGM. There was little difference between groups in behaviour changes associated with the intervention as measured using the Hypoglycaemia Fear Survey (HFS II) (<a href="./references#CD009613-bbs2-0047" title="LamAY , XinX , TanWB , GardnerDS , GohSY . Psychometric validation of the Hypoglycemia Fear Survey‐II (HFS‐II) in Singapore. BMJ Open Diabetes Research and Care2017;5:e000329. [DOI: 10.1136/bmjdrc‐2016‐000329] ">Lamb 2017</a>) behaviour subscale at 34 weeks' gestation (mean difference (MD) 1.00, 95% CI ‐1.06 to 3.06; 1 study, 214 women, <a href="./references#CD009613-fig-0011" title="">Analysis 1.8</a>). The 15 items in HFS behaviour subscale measures behaviours aimed at avoiding hypoglycaemia and its possible negative consequences, with higher scores indicating higher fear of hypoglycaemia, with scores ranging from zero to 60. </p> <p>There was also little difference in sense of well‐being and quality of life as measured using the Short‐Form‐12 (SF‐12) and Problem Areas in Diabetes (PAID) (<a href="./references#CD009613-bbs2-0070" title="VenkataramanK , TanLS , BautistaDC , GrivaK , ZunigaYL , AmirM , et al. Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore. PLOS One2015;10(9):e0136759. ">Venkataraman 2015</a>) which were measured at 34 weeks' gestation (total score) (MD ‐0.70, 95% CI ‐2.50 to 1.10; 1 study, 214 women, <a href="./references#CD009613-fig-0012" title="">Analysis 1.9</a>) (MD 0.80, 95% CI ‐3.06 to 4.66; 1 study, 214 women, <a href="./references#CD009613-fig-0013" title="">Analysis 1.10</a>). The Short‐Form‐12 (SF‐12) is a health‐related quality‐of‐life questionnaire. It consists of 12 questions that measure eight domains assessing physical and mental health. Physical health domains include General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP). Mental health domains include Vitality (VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH). The instrument has been validated across a number of chronic diseases and conditions. Physical and Mental Health Composite Scales combine the 12 items, with a high score of 50 equating to good mental and physical health (<a href="./references#CD009613-bbs2-0035" title="HuoT , GuoY , ShenkmanE , MullerK . Assessing the reliability of the short form 12 (SF‐12) health survey in adults with mental health conditions: a report from the wellness incentive and navigation (WIN) study. Health and Quality of Life Outcomes2018;16(34):1‐9. [DOI: https://doi.org/10.1186/s12955‐018‐0858‐2] ">Huo 2018</a>). The Problem Areas in Diabetes (PAID) instrument was developed to measure emotional distress in people with diabetes. It is a 20‐item scale consisting of emotional problems commonly reported in type 1 and type 2 diabetes mellitus, and has been found to be a valid and reliable scale in Western populations (<a href="./references#CD009613-bbs2-0070" title="VenkataramanK , TanLS , BautistaDC , GrivaK , ZunigaYL , AmirM , et al. Psychometric Properties of the Problem Areas in Diabetes (PAID) Instrument in Singapore. PLOS One2015;10(9):e0136759. ">Venkataraman 2015</a>), with scores ranging from zero to 100, with higher scores reflecting greater emotional distress. The CGM group scored slightly higher in their Blood Glucose Monitoring System Rating Questionnaire (BGMSRQ) (<a href="./references#CD009613-bbs2-0059" title="PeyrotM , RubinRR . Patient‐reported outcomes for an integrated real‐time continuous glucose monitoring/insulin pump system mark. Diabetes Technology and Therapeutics2009;11(1):57‐62. ">Peyrot 2009</a>) total score at 34 weeks' gestation (MD 4.30, 95% CI 0.73 to 7.87; 1 study, 214 women, <a href="./references#CD009613-fig-0014" title="">Analysis 1.11</a>). This questionnaire aims to measure different aspects about the method of blood glucose monitoring: measures relate to convenience, interference, burden, control, overall satisfaction, desire to switch monitoring system, willingness to recommend current monitoring system, and comparison of current and prior blood glucose monitoring system. </p> <p>CGM may make little or no difference to maternal glycaemic control as indicated by HbA1c levels (glycated haemoglobin): the mean HbA1c level in the continuous monitoring group was 0.37% lower, 0.78% lower to 0.04% higher (MD ‐0.37 %, 95% CI ‐0.78 to 0.04; 2 studies, 258 women; I<sup>2</sup> = 81%, <a href="./references#CD009613-fig-0015" title="">Analysis 1.12</a>) and although more women in the continuous monitoring group achieved HbA1c levels less than or equal to 6.5% (48 mmol/mol) at 34 weeks (RR 1.27, 95% CI 1.00 to 1.62; 1 study, 187 women, <a href="./references#CD009613-fig-0016" title="">Analysis 1.13</a>), the results are based on a single study. </p> <p>There was no clear difference between groups for the following outcomes.</p> <p> <ol id="CD009613-list-0022"> <li> <p>Maternal hypoglycaemia (severe) (RR 0.92, 95% CI 0.43 to 1.95; 1 study,154 women, <a href="./references#CD009613-fig-0017" title="">Analysis 1.14</a>) </p> </li> <li> <p>Miscarriage (RR 1.24, 95% CI 0.47 to 3.26; 3 studies, 439 women, <a href="./references#CD009613-fig-0018" title="">Analysis 1.15</a>) </p> </li> <li> <p>Stillbirth (RR 0.34, 95% CI 0.01 to 8.17; 1 study, 211 infants, <a href="./references#CD009613-fig-0019" title="">Analysis 1.16</a>) </p> </li> <li> <p>Neonatal mortality (RR 0.92, 95% CI 0.13 to 6.37; 2 studies, 256 infants, <a href="./references#CD009613-fig-0020" title="">Analysis 1.17</a>) </p> </li> <li> <p>Gestational age at birth (weeks) (MD 0.10 weeks, 95% CI ‐0.57 to 0.77; 1 study, 68 women, <a href="./references#CD009613-fig-0021" title="">Analysis 1.18</a>) </p> </li> <li> <p>Preterm birth &lt; 37 weeks (RR 0.96, 95% CI 0.72 to 1.29; 3 studies, 430 women, <a href="./references#CD009613-fig-0022" title="">Analysis 1.19</a>) </p> </li> <li> <p>Preterm birth &lt; 34 weeks (RR 0.46, 95% CI 0.17 to 1.28; 1 study, 211 women, <a href="./references#CD009613-fig-0023" title="">Analysis 1.20</a>) </p> </li> <li> <p>Macrosomia (average RR 0.84, 95% CI 0.61 to 1.17; 3 studies, 451 women, I<sup>2</sup> = 34%, <a href="./references#CD009613-fig-0024" title="">Analysis 1.21</a>) </p> </li> <li> <p>Birthweight (kg) (MD ‐0.13 kg, 95% CI ‐0.38 to 0.12; 2 studies, 267 infants, I<sup>2</sup> = 49%, <a href="./references#CD009613-fig-0025" title="">Analysis 1.22</a>) </p> </li> <li> <p>Small‐for‐gestational age (RR 2.40, 95% CI 0.55 to 10.51; 2 studies, 269 infants, <a href="./references#CD009613-fig-0026" title="">Analysis 1.23</a>) </p> </li> <li> <p>Head circumference (cm) (MD ‐0.20, 95% CI ‐0.79 to 0.39; 1 study, 160 infants, <a href="./references#CD009613-fig-0027" title="">Analysis 1.24</a>) </p> </li> <li> <p>Length (crown‐heel length cm) (MD ‐0.20, 95% CI ‐0.79 to 0.39; 1 study, 160 infants, <a href="./references#CD009613-fig-0028" title="">Analysis 1.25</a>) </p> </li> <li> <p>Adipositiy (sum of four skin folds mm) (MD ‐0.20, 95% CI ‐1.98 to 1.58; 1 study, 160 infants, <a href="./references#CD009613-fig-0029" title="">Analysis 1.26</a>) </p> </li> <li> <p>Shoulder dystocia (RR 3.00, 95% CI 0.12 to 72.77; 1 study, 200 infants, <a href="./references#CD009613-fig-0030" title="">Analysis 1.27</a>) </p> </li> <li> <p>Respiratory distress syndrome (RR 1.00, 95% CI 0.41 to 2.41; 1 study, 200 infants, <a href="./references#CD009613-fig-0031" title="">Analysis 1.28</a>) </p> </li> <li> <p>Neonatal hypoglycaemia (RR 0.66, 95% CI 0.48 to 0.93; 3 studies, 428 infants, <a href="./references#CD009613-fig-0032" title="">Analysis 1.29</a>) </p> </li> <li> <p>Neonatal hyperbilirubinaemia (RR 0.81, 95% CI 0.52 to 1.26; 1 study, 200 infants, <a href="./references#CD009613-fig-0033" title="">Analysis 1.30</a>) </p> </li> <li> <p>Relevant biomarkers associated with the intervention (cord blood c‐peptide levels &gt; 566 pmol/L) (RR 0.95, 95% CI 0.68 to 1.33; 1 study, 200 infants, <a href="./references#CD009613-fig-0034" title="">Analysis 1.31</a>) </p> </li> <li> <p>Relevant biomarkers associated with the intervention (cord blood c‐peptide levels &gt; 2725 pmol/L) (RR 1.00, 95% CI 0.33 to 3.00; 1 study, 200 infants, <a href="./references#CD009613-fig-0035" title="">Analysis 1.32</a>) </p> </li> <li> <p>Major and minor anomalies (RR 0.71, 95% CI 0.16 to 3.13; 2 studies, 285 infants, <a href="./references#CD009613-fig-0036" title="">Analysis 1.33</a>) </p> </li> <li> <p>Number of hospital admissions (mother) (RR 1.25, 95% CI 0.84 to 1.85; 1 study, 207 women, <a href="./references#CD009613-fig-0037" title="">Analysis 1.34</a>) </p> </li> <li> <p>Neonatal intensive care unit admissions (average RR 0.76, 95% CI 0.42 to 1.35; 2 studies, 274 infants, <a href="./references#CD009613-fig-0038" title="">Analysis 1.35</a>) </p> </li> <li> <p>Birth trauma (shoulder dystocia, bone fracture, nerve palsy) (RR 5.00, 95% CI 0.24 to 102.85; 1 study, 200 infants, <a href="./references#CD009613-fig-0040" title="">Analysis 1.37</a>) </p> </li> <li> <p>Diabetic ketoacidosis (RR 1.01, 95% CI 0.14 to 7.03; 1 study, 207 women, <a href="./references#CD009613-fig-0041" title="">Analysis 1.38</a>) </p> </li> </ol> </p> <p>It may reduce neonatal hypoglycaemia (RR 0.66, 95% CI 0.48 to 0.93; 3 studies, 428 infants, <a href="./references#CD009613-fig-0032" title="">Analysis 1.29</a>) and NICU admission of more than 24 hours (RR 0.63, 95% CI 0.42 to 0.93; 1 study, 200 infants, <a href="./references#CD009613-fig-0039" title="">Analysis 1.36</a>). </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> <section id="CD009613-sec-0121"> <h4 class="title">Comparison 2 ‐ Self‐monitoring versus a different type of self‐monitoring</h4> <p>See <a href="./full#CD009613-tbl-0002">summary of findings Table 2</a>. </p> <p>Two trials (<a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>) compared self‐monitoring with a different type of self‐monitoring (standard care). In one trial (<a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>), a total of 13 pregnant women with T1DM were randomly allocated into self‐monitoring of blood glucose (SMBG) at home, seven times a day, twice per week. Another six women were allocated to standard care (urine check four times daily) and random blood glucose testing measured fortnightly during clinic visits. </p> <p>In the other trial (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), 30 T1DM women were assigned to self‐monitoring (n = 15) and standard care (n = 15). The self‐monitoring group carried out daily home glucose monitoring four times daily and the standard care group carried out weekly venipuncture three times daily, measured on one day weekly. One woman in each group had a first trimester spontaneous miscarriage, so results are presented for the remaining 28 women and infants. The self‐monitoring group was required to monitor fasting plus two‐hour post‐prandial morning, afternoon and evening glucose daily, while the standard care group were measured one day per week. </p> <section id="CD009613-sec-0122"> <h5 class="title">Primary outcomes</h5> <p>It is uncertain whether self‐monitoring reduces the risk of caesarean section (risk ratio (RR) 0.78, 95% confidence interval (CI) 0.40 to 1.49, 1 study, 28 women, <a href="./references#CD009613-fig-0042" title="">Analysis 2.1</a>, very low‐quality evidence) (<a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>). <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a> also reported perinatal mortality and it was too small to show any differences between groups (perinatal mortality: RR 3.00, 95% CI 0.13 to 67.91, 1 study, 28 infants, very low‐quality evidence, <a href="./references#CD009613-fig-0043" title="">Analysis 2.2</a>). </p> <p>Hypertensive disorders of pregnancy, large‐for‐gestational age, neonatal mortality and morbidity composite and neurosensory disability were not reported in either study. </p> </section> <section id="CD009613-sec-0123"> <h5 class="title">Secondary outcomes</h5> <p>It is uncertain whether self‐monitoring makes any difference in maternal glycaemic control for post‐prandial blood glucose (MD ‐0.70 mmol/L, 95% CI ‐2.15 to 0.75; 1 study, 13 women, <a href="./references#CD009613-fig-0044" title="">Analysis 2.3</a>), or HbA1c (MD ‐0.10 %, 95% CI ‐1.93 to 1.73, 1 study, 28 women, <a href="./references#CD009613-fig-0045" title="">Analysis 2.4</a>). There were too few women to show any differences in miscarriage (RR 1.00, 95% CI 0.07 to 14.55, 1 study, 30 women, <a href="./references#CD009613-fig-0046" title="">Analysis 2.5</a>), neonatal mortality (RR 3.00, 95% CI 0.13 to 67.91, 1 study, 28 women, <a href="./references#CD009613-fig-0047" title="">Analysis 2.6</a>), or respiratory distress syndrome (RR 3.00, 95% CI 0.13 to 67.91, 1 study, 28 infants, <a href="./references#CD009613-fig-0050" title="">Analysis 2.9</a>). It is uncertain whether there are any differences in gestational age between self‐monitoring groups (MD 0.40 weeks, 95% CI ‐1.65 to 2.45, 1 study, 28 infants, <a href="./references#CD009613-fig-0048" title="">Analysis 2.7</a>), and or in infant birthweight (MD ‐0.18 kg, 95% CI ‐0.49 to 0.13, 2 studies, 41 infants, <a href="./references#CD009613-fig-0049" title="">Analysis 2.8</a>) due to limitations in small sample sizes. </p> <p>Again it is uncertain whether there are any differences for neonatal hypoglycaemia (RR 0.57, 95% CI 0.21 to 1.52, 1 study, 28 infants, <a href="./references#CD009613-fig-0051" title="">Analysis 2.10</a>), neonatal jaundice (hyperbilirubinaemia) (RR 0.56, 95% CI 0.25 to 1.24, 1 study, 28 infants, <a href="./references#CD009613-fig-0052" title="">Analysis 2.11</a>), hypocalcaemia (RR 1.00, 95% CI 0.07 to 14.45, 1 study, 28 infants, <a href="./references#CD009613-fig-0053" title="">Analysis 2.12</a>), polycythaemia (RR 0.33, 95% CI 0.01 to 7.55, 1 study, 28 infants, <a href="./references#CD009613-fig-0054" title="">Analysis 2.13</a>) and neonatal cord vein C‐peptide (MD 0.13 ng/nl, 95% CI ‐0.50 to 0.76, 1 study, 28 infants, <a href="./references#CD009613-fig-0055" title="">Analysis 2.14</a>). </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> <section id="CD009613-sec-0124"> <h4 class="title">Comparison 3 ‐ Self‐monitoring at home versus hospitalisation</h4> <p>See <a href="./full#CD009613-tbl-0003">summary of findings Table 3</a>. </p> <p>Only one study compared home self‐monitoring with hospitalisation (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>). In this study, a total of 100 pregnant women with T1DM and T2DM were randomised. The home self‐monitoring group had 54 women while the hospital group had 46 women. The women from the home group self‐monitored their blood glucose from the 32<sup>nd</sup> until 36<sup>th</sup> week of gestation and then were hospitalised during the 37<sup>th</sup> week until delivery; the hospital group women were hospitalised from 32<sup>nd</sup> week until delivery. Blood glucose was monitored four times daily (7 AM, 9.30 AM, 3 PM and 7 PM) in both groups. </p> <section id="CD009613-sec-0125"> <h5 class="title">Primary outcomes</h5> <p>This study of 100 women did not report on the composite outcome, hypertensive disorders of pregnancy. It reported pre‐eclampsia and hypertension in pregnancy, but as separate outcomes<b>.</b> </p> <p>The results were uncertain for caesarean section (RR 0.96, 95% CI 0.65 to 1.44, <a href="./references#CD009613-fig-0057" title="">Analysis 3.2</a>, very low‐quality evidence<i>),</i> and the sample size was too small to assess perinatal mortality (RR 0.85, 95% CI 0.05 to 13.24, <a href="./references#CD009613-fig-0058" title="">Analysis 3.3</a>, very low‐quality evidence<i>).</i> </p> <p>Large‐for‐gestational age, mortality or morbidity composite, and neurosensory disability were not reported. </p> </section> <section id="CD009613-sec-0126"> <h5 class="title">Secondary outcomes</h5> <p>It is uncertain whether there is any difference between self‐monitoring and hospitalisation were shown in the reported secondary outcomes: placental abruption (RR 1.70, 95% CI 0.16 to 18.19, <a href="./references#CD009613-fig-0061" title="">Analysis 3.6</a>); preterm birth &lt; 37 weeks (RR 0.85, 95% CI 0.45 to 1.60, <a href="./references#CD009613-fig-0062" title="">Analysis 3.7</a>); respiratory distress syndrome (RR 2.56, 95% CI 0.28 to 23.74, <a href="./references#CD009613-fig-0063" title="">Analysis 3.8</a>); neonatal hypoglycaemia (RR 1.01, 95% CI 0.50 to 2.03, <a href="./references#CD009613-fig-0064" title="">Analysis 3.9</a>); neonatal jaundice (hyperbilirubinaemia) (RR 2.27, 95% CI 0.64 to 8.07, <a href="./references#CD009613-fig-0065" title="">Analysis 3.10</a>); major anomalies (RR 0.27, 95% CI 0.03 to 2.54, <a href="./references#CD009613-fig-0066" title="">Analysis 3.11</a>). </p> <p>As would be expected from the nature of the intervention, a lower proportion of women in the self‐monitoring group had antenatal hospital admission (RR 0.19, 95% CI 0.11 to 0.33, <a href="./references#CD009613-fig-0067" title="">Analysis 3.12</a>). </p> <p>Maternal glycaemic control was reported, however only mean blood glucose was given without standard deviations, and HbA1c was only presented graphically, so we were not able to include these data in the analyses. The mean blood glucose values during the study period were 6.0 mmol/L for the hospital group and 5.9 mmol/L for the home group. </p> </section> <section id="CD009613-sec-0127"> <h5 class="title">Outcomes that were not pre‐specified</h5> <p>There were no differences between self‐monitoring and hospitalisation in terms of feeding difficulties (RR 0.85, 95% CI 0.41 to 1.78, <a href="./references#CD009613-fig-0068" title="">Analysis 3.13</a>). </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> <section id="CD009613-sec-0128"> <h4 class="title">Comparison 4 ‐ Pre‐prandial versus post‐prandial glucose monitoring</h4> <p>See <a href="./full#CD009613-tbl-0004">summary of findings Table 4</a>. </p> <p>Only one trial compared pre‐prandial and post‐prandial glucose monitoring (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>). Sixty‐one T1DM women were randomly assigned to pre‐prandial (n = 31) or post‐prandial (n = 30) blood glucose monitoring. The pre‐prandial group monitored their blood glucose before breakfast and pre‐prandially for each meal. The post‐prandial group monitored blood glucose after breakfast and one hour after the commencement of each meal. </p> <section id="CD009613-sec-0129"> <h5 class="title">Primary outcomes</h5> <p>In one study of 61 women (61 infants), it is uncertain whether there is any difference between pre‐prandial and post‐prandial glucose monitoring for caesarean section (RR 1.45, 95% CI 0.92 to 2.28, <a href="./references#CD009613-fig-0069" title="">Analysis 4.1</a>, very low‐quality evidence), large‐for‐gestational age (RR 1.16, 95% CI 0.73 to 1.85; <a href="./references#CD009613-fig-0070" title="">Analysis 4.2</a>, very low‐quality evidence<i>)</i> and perinatal mortality (RR 2.91, 95% CI 0.12 to 68.66, <a href="./references#CD009613-fig-0071" title="">Analysis 4.3</a>, very low‐quality evidence). </p> <p>The study did not report the composite outcomes, hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia), mortality or morbidity composite, or neurosensory disability. </p> </section> <section id="CD009613-sec-0130"> <h5 class="title">Secondary outcomes</h5> <p>It is uncertain whether there are any differences between pre‐prandial and post‐prandial glucose monitoring for the following outcomes: pre‐eclampsia (RR 6.43, 95% CI 0.82 to 50.11, <a href="./references#CD009613-fig-0072" title="">Analysis 4.4</a>); weight gain in pregnancy (MD ‐0.90 kg, 95% CI ‐3.86 to 2.06, <a href="./references#CD009613-fig-0073" title="">Analysis 4.5</a>); use of additional pharmacotherapy shown by insulin dose in units/day and units/kg (MD ‐17.40 units/day, 95% CI ‐43.41 to 8.61, <a href="./references#CD009613-fig-0074" title="">Analysis 4.6</a>; MD ‐0.20 units/kg, 95% CI ‐0.45 to 0.05, <a href="./references#CD009613-fig-0075" title="">Analysis 4.7</a>); glycaemic control shown by mean HbA1c (MD 0.30 %, 95% CI ‐0.08 to 0.68, <a href="./references#CD009613-fig-0076" title="">Analysis 4.8</a>); stillbirth (RR 2.91, 95% CI 0.12 to 68.66, <a href="./references#CD009613-fig-0077" title="">Analysis 4.9</a>); gestational age at birth (MD 0.20 weeks, 95% CI ‐0.84 to 1.24, <a href="./references#CD009613-fig-0078" title="">Analysis 4.10</a>)<i>;</i> preterm birth &lt; 37 weeks (RR 1.33, 95% CI 0.62 to 2.84, <a href="./references#CD009613-fig-0079" title="">Analysis 4.11</a>)<i>;</i> macrosomia (RR 2.18, 95% CI 0.75 to 6.32, <a href="./references#CD009613-fig-0080" title="">Analysis 4.12</a>), birthweight (MD 0.24 kg, 95% CI ‐0.10 to 0.58, <a href="./references#CD009613-fig-0081" title="">Analysis 4.13</a>); subscapular skinfold thickness (adiposity) (MD 0.60 mm, 95% CI ‐0.18 to 1.38, <a href="./references#CD009613-fig-0082" title="">Analysis 4.14</a>); birth trauma (shoulder dystocia, bone fracture, nerve palsy) (RR 0.48, 95% CI 0.05 to 5.06, <a href="./references#CD009613-fig-0084" title="">Analysis 4.16</a>); respiratory distress syndrome (RR 0.97, 95% CI 0.06 to 14.78, <a href="./references#CD009613-fig-0085" title="">Analysis 4.17</a>); neonatal hypoglycaemia (RR 1.09, 95% CI 0.48 to 2.45, <a href="./references#CD009613-fig-0086" title="">Analysis 4.18</a>); neonatal jaundice (hyperbilirubinaemia) (RR 1.16, 95% CI 0.40 to 3.40, <a href="./references#CD009613-fig-0087" title="">Analysis 4.19</a>); cord IGF‐1 (MD 1.30 μg/L, 95% CI ‐0.70 to 3.30, <a href="./references#CD009613-fig-0088" title="">Analysis 4.20</a>); neonatal glucose at age one hour (not pre‐specified) (MD ‐0.20, 95% CI ‐0.88 to 0.48, <a href="./references#CD009613-fig-0089" title="">Analysis 4.21</a>); transient tachypnoea (not pre‐specified) (RR 2.58, 95% CI 0.76 to 8.81, <a href="./references#CD009613-fig-0090" title="">Analysis 4.22</a>); and neonatal intensive care admissions (RR 1.04, 95% CI 0.62 to 1.74, <a href="./references#CD009613-fig-0091" title="">Analysis 4.23</a>). </p> <p>Infants in the pre‐prandial monitoring group had higher triceps skinfold thickness (adiposity) (MD 0.60 mm, 95% CI 0.04 to 1.16, <a href="./references#CD009613-fig-0083" title="">Analysis 4.15</a>), although the difference is small and should be considered in the context of no clear difference in large‐for‐gestational age, birthweight, macrosomia, and subscapular skinfold thickness. </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> <section id="CD009613-sec-0131"> <h4 class="title">Comparison 5 ‐ Automated telemedicine monitoring versus conventional system</h4> <p>See <a href="./full#CD009613-tbl-0005">summary of findings Table 5</a>. </p> <p>Three studies (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>) compared automated telemedicine monitoring versus conventional system. <a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a> included both pregnant women with T1DM (n = 32, data included in this review) and women with gestational diabetes (n = 203, data excluded from this review). Women in the telemedicine group were asked to submit their blood glucose data every week, and had a medical examination at the diabetes clinic once a month, while women in the control group had a medical examination every two weeks. <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a> (n = 20) and <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> (n = 32) recruited T1DM women. <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a> used a DIANET system, which was an automated monitoring system using a telemedicine system with patient unit, diabetes workstation and the communication link to send all data to the diabetologist. The intermittent monitoring was conventional monitoring where the women were instructed to perform three or more tests of blood glucose per day using BM20‐800 strips with the results checked during routine clinic visits. <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> used a telematic management system with the a glucometer connected to a modem interface where the blood glucose measurements could be transmitted to the central clinical control unit. The conventional group would only have their measurements examined during the routine clinical examinations every three weeks. All women (in both groups) were encouraged to measure their blood glucose at least six times per day. </p> <section id="CD009613-sec-0132"> <h5 class="title">Primary outcomes</h5> <p>Again, it is uncertain from one study (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>) whether there is any difference between automated telemedicine monitoring and conventional monitoring for caesarean section (RR 0.96, 95% CI 0.62 to 1.48, 1 study, 32 women, <a href="./references#CD009613-fig-0092" title="">Analysis 5.1</a>, very low‐quality evidence<i>)</i> and the composite of neonatal mortality or morbidity (RR 1.18, 95% CI 0.53 to 2.62, 1 study, 32 infants, <a href="./references#CD009613-fig-0093" title="">Analysis 5.2</a>). </p> <p><a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a> and <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a> did not report these primary outcomes, and none of the studies contributing data to this comparison reported hypertensive disorders of pregnancy, large‐for‐gestational age, perinatal mortality (stillbirth and neonatal mortality), and neurosensory disability. </p> </section> <section id="CD009613-sec-0133"> <h5 class="title">Secondary outcomes</h5> <p>In one study of 20 women (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>), women in the automated telemedicine group had a higher mean insulin requirement at the end of the study (MD 18.40 units/day, 95% CI 12.88 to 23.92, <a href="./references#CD009613-fig-0096" title="">Analysis 5.5</a>). The women in the automated telemedicine group also had lower mean maternal fasting blood glucose before breakfast and before lunch at the end of the study (before breakfast: MD ‐1.00 mmol/L, 95% CI ‐1.22 to ‐0.78, <a href="./references#CD009613-fig-0097" title="">Analysis 5.6</a>; before lunch: MD ‐1.10 mmol/L, 95% CI ‐1.32 to ‐0.88, <a href="./references#CD009613-fig-0098" title="">Analysis 5.7</a>). There was high heterogeneity between studies for maternal HbA1c (random‐effects MD ‐0.17 %, 95% CI ‐0.82 to 0.48, 3 studies, 82 women, Tau² = 0.27, I² = 82%, <a href="./references#CD009613-fig-0099" title="">Analysis 5.8</a>) and maternal post‐prandial blood glucose (random‐effects MD ‐0.80 mmol/L, 95% CI ‐1.67 to 0.08, 3 studies, 50 women,Tau² = 0.35, I² = 86%, <a href="./references#CD009613-fig-0100" title="">Analysis 5.9</a>). Post hoc sensitivity analyses show that this was due to measurements from <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>. This study showed differences between groups in HbA1c and post‐prandial blood glucose, however the other two studies did not. It seems likely that the higher insulin doses given to women in the automated telemedicine group resulted in lower blood glucose measures. </p> <p>It was uncertain whether there was any difference between groups for: weight gain in pregnancy (MD ‐0.70, 95% CI ‐4.95 to 3.55, 1 study, 32 women, <a href="./references#CD009613-fig-0101" title="">Analysis 5.10</a>); use of additional insulin therapy (RR 1.00, 95% CI 0.89 to 1.12, 1 study, 32 women, <a href="./references#CD009613-fig-0095" title="">Analysis 5.4</a>); gestational age (MD 0.24 weeks, 95% CI ‐0.39 to 0.88, 3 studies, 84 women,<a href="./references#CD009613-fig-0094" title="">Analysis 5.3</a>); macrosomia (RR 1.18, 95% CI 0.31 to 4.43, 1 study, 32 infants, <a href="./references#CD009613-fig-0102" title="">Analysis 5.11</a>); or birthweight (MD ‐0.16 kg, 95% CI ‐0.64 to 0.32, 1 study, 32 infants, <a href="./references#CD009613-fig-0103" title="">Analysis 5.12</a>). </p> <p>The percentage of maternal hypoglycaemic episodes was reported by <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>, however, the total of all blood glucose data were not available, therefore the frequency was not estimable. </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> <section id="CD009613-sec-0134"> <h4 class="title">Comparison 6 ‐ Constant CGM versus intermittent CGM</h4> <p>See <a href="./full#CD009613-tbl-0006">summary of findings Table 6</a>. </p> <p>Only one study compared constant CGM and intermittent CGM (<a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>). Twenty‐five T1DM women were randomised into constant CGM (n = 12) and intermittent CGM (n = 13) groups. The women in the constant CGM group wore the glucose sensor 24 hours per day while the intermittent CGM group wore the glucose sensor 14 days per month. The women in the intermittent CGM group measured blood glucose at least six times daily when not using the glucose sensor. </p> <section id="CD009613-sec-0135"> <h5 class="title">Primary outcomes</h5> <p>It is uncertain whether constant CGM makes any difference to rates of caesarean section (RR 0.77, 95% CI 0.33 to 1.79, 1 study, 25 women, very low‐quality evidence, <a href="./references#CD009613-fig-0104" title="">Analysis 6.1</a>). Other primary outcomes were not reported (hypertensive disorders of pregnancy, large‐for‐gestational age, perinatal mortality (stillbirth and neonatal mortality), mortality or morbidity composite, and neurosensory disability). </p> </section> <section id="CD009613-sec-0136"> <h5 class="title">Secondary outcomes</h5> <p>Constant CGM makes little or no difference to weight gain in pregnancy (MD 0.50 kg, 95% CI ‐1.82 to 2.82, 1 study, 25 women, <a href="./references#CD009613-fig-0105" title="">Analysis 6.2</a>), insulin dosage (third trimester: MD ‐0.03, 95% CI ‐1.30 to 1.24, 1 study, 25 women, <a href="./references#CD009613-fig-0106" title="">Analysis 6.3</a>); maternal blood glucose (first trimester: MD ‐0.50 mmol/L, 95% CI ‐2.70 to 1.70, 1 study, 25 women, <a href="./references#CD009613-fig-0107" title="">Analysis 6.4</a>; third trimester: MD ‐0.14 mmol/L, 95% CI ‐2.00 to 1.72, 1 study, 25 women, <a href="./references#CD009613-fig-0108" title="">Analysis 6.5</a>); maternal HbA1c (first trimester: MD ‐0.30 %, 95% CI ‐1.13 to 0.53, 1 study, 25 women, <a href="./references#CD009613-fig-0109" title="">Analysis 6.6</a>; third trimester: MD ‐0.09 %, 95% CI ‐0.69 to 0.51, 1 study, 25 women, <a href="./references#CD009613-fig-0110" title="">Analysis 6.7</a>), maternal hypoglycaemia (RR 0.54, 95% CI 0.06 to 5.24, 1 study, 25 women, <a href="./references#CD009613-fig-0111" title="">Analysis 6.8</a>), diabetic ketoacidosis (not pre‐specified) (RR 0.36, 95% CI 0.02 to 8.05, 1 study, 25 women, <a href="./references#CD009613-fig-0112" title="">Analysis 6.9</a>), preterm birth &lt; 37 weeks (RR 1.08, 95% CI 0.08 to 15.46, 1 study, 25 infants, <a href="./references#CD009613-fig-0113" title="">Analysis 6.10</a>), and macrosomia (RR 1.08, 95% CI 0.08 to 15.46, 1 study, 25 infants, <a href="./references#CD009613-fig-0114" title="">Analysis 6.11</a>). There were no events for neonatal hypoglycaemia (1 study, 25 infants <a href="./references#CD009613-fig-0115" title="">Analysis 6.12</a>). </p> <p>None of the studies reported on our remaining secondary outcomes.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009613-sec-0137" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009613-sec-0137"></div> <section id="CD009613-sec-0138"> <h3 class="title" id="CD009613-sec-0138">Summary of main results</h3> <p>The objective of this review was to assess the various techniques of glucose monitoring among pregnant women with pre‐existing type 1 and type 2 diabetes and their impact on maternal and infant outcomes. We included 12 trials comparing six different pairs of glucose monitoring techniques: continuous glucose monitoring (CGM) versus intermittent glucose monitoring (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>), self‐monitoring versus a different type of self‐monitoring (<a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>), self‐monitoring versus hospitalisation (<a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>), pre‐prandial versus post‐prandial glucose monitoring (<a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>), automated telemedicine monitoring versus conventional (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>; <a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), and constant CGM versus intermittent CGM (<a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>). This review update includes a total of 12 trials (944) women (type 1 diabetes: 660 women; type 2 diabetes: 113 women; type 1 or type 2 (unspecified): 171 women. All trials originated from European countries, the USA and Canada. </p> <p>With the addition of two new studies (406 women) to one of the comparisons (comparison 1 ‐ continuous glucose monitoring (CGM) versus intermittent glucose monitoring), the evidence suggests that CGM may reduce hypertensive disorders of pregnancy, though it should be noted that only two of the four relevant studies reported data for this composite outcome. Conversely, this did not translate into a clear reduction for pre‐eclampsia. There was no clear reduction in caesarean section or large‐for‐gestational age with CGM. There was not enough evidence to assess perinatal mortality or mortality or morbidity composite as the evidence was based on single studies of low quality. CGM appears to reduce neonatal hypoglycaemia. Neurosensory disability was not reported. </p> <p>For the remaining five comparisons: self‐monitoring versus a different type of self‐monitoring (two studies, 43 women); self‐monitoring at home versus hospitalisation (one study, 100 women); pre‐prandial versus post‐prandial glucose monitoring (one study, 61 women); automated telemedicine monitoring versus conventional system (three studies, 84 women); and constant CGM versus intermittent CGM (one study, 25 women), it is uncertain whether any of the interventions has any impact on any of our GRADE outcomes (hypertensive disorders of pregnancy, caesarean section, large‐for‐gestational age) because the quality of the evidence was found to be very low. There was not enough evidence to assess perinatal mortality and neonatal mortality and morbidity composite. Other important outcomes, such as neurosensory disability, were not reported in any of these comparisons. </p> <p>Outcomes relating to cost were not reported by any of the studies. Resource use (antenatal hospital admissions, neonatal intensive care admissions and neonatal intensive care unit length of admission &gt; 24 hours) was reported only by single trials in three out of the six comparisons and so pooling of data was not possible. </p> </section> <section id="CD009613-sec-0139"> <h3 class="title" id="CD009613-sec-0139">Overall completeness and applicability of evidence</h3> <p>With the addition of two new studies (406 women) to one of the comparisons examining CGM versus intermittent monitoring, there was evidence to suggest that CGM may have an impact on hypertensive disorders of pregnancy, although there was no clear reduction for other outcomes associated with hypertension, such as pre‐eclampsia. The pooling of the data for hypertension disorders needs to be viewed with caution. Only two of the four relevant studies reported on this composite outcome of 'hypertensive disorders of pregnancy' including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia, and they report it slightly differently (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>). <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> reports a composite of pre‐eclampsia and pregnancy‐induced hypertension for women with both type 1 and type 2 diabetes and <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> reports a composite of worsening chronic, gestational hypertension and pre‐eclampsia for women with only type 1 diabetes. The ‘worsening chronic’ could be omitted from the analysis to make the two randomised controlled trials (RCTs) more comparable for pooling, although this makes only a small difference to the overall results (17/100 CGM and 27/102 versus 18/100 and 28/102). The real issue is that <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a> and <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a> cannot be included in the analysis for this composite outcome because they both only report on pre‐eclampsia and not on pregnancy‐induced hypertension. The results for pre‐eclampsia therefore must be considered the most robust result in terms of complete reporting as all four RCTs report on it. The evidence base for the effectiveness of other monitoring techniques analysed in the other five comparisons is weak and based on mainly single studies with very low‐quality evidence and cannot be said to justify overall completeness of evidence. </p> <p>All the included trials were conducted in Western countries ‐ Europe, the USA and Canada ‐ and it can be assumed that a majority of the women were Caucasian. Most of the pregnant women in the included studies had type 1 diabetes (n = 792) with much fewer having type 2 diabetes (n = 152). There were six pairs of intervention techniques in the included trials. There was difficulty in pooling the results due to this variation. The review's primary outcome, neurosensory disability, was not reported in any of the trials. The only secondary health service use outcomes reported were antenatal hospital admission, neonatal intensive care admissions and neonatal intensive care unit length of admission &gt; 24 hours. Many of the reviews secondary maternal and perinatal/neonatal outcomes were not reported: induction of labour, perineal trauma, postpartum haemorrhage, postpartum infection, adherence to the intervention, maternal mortality, Apgar score (less than seven at five minutes). No studies reported long‐term maternal or infant outcomes and patient‐reported outcomes such as behaviour changes associated with the intervention and sense of well‐being and quality of life. </p> </section> <section id="CD009613-sec-0140"> <h3 class="title" id="CD009613-sec-0140">Quality of the evidence</h3> <p>Three of the 12 included studies were at low risk of bias (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>), eight studies were at moderate risk of bias (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>), and one study was at high risk of bias (<a href="./references#CD009613-bbs2-0001" title="DalfràMG , NicolucciA , LapollaA , TISG . The effect of telemedicine on outcome and quality of life in pregnant women with diabetes. Journal of Telemedicine &amp; Telecare2009;15(5):238‐42. ">Dalfrà 2009</a>). Five trials (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Secher-2013" target="_blank">Secher 2013</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Varner-1983" target="_blank">Varner 1983</a>; <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>) described the random sequence generation while adequate and secure concealment of allocation was described in four trials (<a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Manderson-2003" target="_blank">Manderson 2003</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Murphy-2008" target="_blank">Murphy 2008</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Secher-2013" target="_blank">Secher 2013</a>). It was unclear if there was any selective reporting in one trial (<a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Dalfr_x00e0_-2009" target="_blank">Dalfrà 2009</a>), while 10 studies reported all expected outcome data (<a href="./references#CD009613-bbs2-0002" title="FalluccaF , DiBiaseN , SabbatiniA , BorrelloE , SciulloE , NapoliA . Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes International.1996;13(4):115‐8. diBiaseN , NapoliA , SabbatiniA , BorrelloE , BuongiornoAM , FalluccaF . Telemedicine in the treatment of diabetic pregnancy. Annali dell Istituto Superiore di Sanita1997;33(3):347‐51. ">di Biase 1997</a>; <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a>; <a href="./references#CD009613-bbs2-0004" title="HansonU , PerssonB , EnochssonE , LennerhagenP , LindgrenF , LundstromV , et al. Self‐monitoring of blood glucose by diabetic women during the third trimester of pregnancy. American Journal of Obstetrics and Gynecology1984;150:817‐21. ">Hanson 1984</a>; <a href="./references#CD009613-bbs2-0005" title="MandersonJ , EnnisC , PattersonC , HaddenD , TraubA . Pre‐eclampsia in type 1 diabetic pregnancy: preprandial versus postprandial capillary blood glucose monitoring. Hypertension in Pregnancy2002;21(Suppl 1):142. MandersonJG , PattersonCC , HaddenDR , TraubAI , EnnisC , McCanceDR . Preprandial versus postprandial blood glucose monitoring in type 1 diabetic pregnancy: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology2003;189:507‐12. ">Manderson 2003</a>; <a href="./references#CD009613-bbs2-0006" title="ISRCTN84461581 . A randomised controlled trial to evaluate the role of the continuous glucose monitoring system (CGMS) in pregnancies complicated by pre‐existing diabetes. isrctn.com/ISRCTN84461581 Date first received: 30 September 2005. MurphyHR , RaymanG , DuffieldK , LewisKS , KellyS , JohalB , et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care2007;30(11):2785‐91. MurphyHR , RaymanG , LewisK , KellyS , JohalB , DuffieldK , et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ2008;337:a1680. ">Murphy 2008</a>; <a href="./references#CD009613-bbs2-0007" title="PetrovskiG , DimitrovskiC , BogoevM , MilenkovicT , AhmetiI , BitovskaI . Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study. Diabetes Technology and Therapeutics2011;13(11):1109‐13. ">Petrovski 2011</a>; <a href="./references#CD009613-bbs2-0008" title="CorduaS , SecherAL , RingholmL , DammP , MathiesenER . Real‐time continuous glucose monitoring during labour and delivery in women with type 1 diabetes ‐ observations from a randomized controlled trial. Diabetic Medicine2013;30(11):1374‐81. NCT00994357 . The effect of real‐time continuous glucose monitoring on severe complications to pregnancy in women with diabetes: a randomised controlled study. clinicaltrials.gov/show/NCT00994357 Date first received: 13 October 2009. SecherAL , MathiesenER , AndersenHU , PeterD , LeneR . Severe hypoglycemia in pregnant women with type 2 diabetes‐ a relevant clinical problem. Diabetes Research and Clinical Practice2013;102(2):e17‐8. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in diabetic pregnancy ‐ a randomised controlled trial. Diabetologia2012;55(Suppl 1):S40. SecherAL , RingholmL , AndersenHU , DammP , MathiesenER . The effect of real‐time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care2013;36:1877‐83. ">Secher 2013</a>; <a href="./references#CD009613-bbs2-0009" title="StubbsSM , AlbertiKG , BrudenellJM , PykeDA , WatkinsPJ , StubbsWA . Management of the pregnant diabetic: home or hospital, with or without glucose meters. Lancet1980;1:1122‐4. ">Stubbs 1980</a>; <a href="./references#CD009613-bbs2-0010" title="VarnerMW . Efficacy of home glucose monitoring in diabetic pregnancy. American Journal of Medicine1983;75:592‐6. ">Varner 1983</a>; <a href="./references#CD009613-bbs2-0012" title="LadyzynskiP , WojcickiJM . Home telecare during intensive insulin treatment‐‐metabolic control does not improve as much as expected. Journal of Telemedicine and Telecare2007;13(1):44‐7. WojcickiJM , LadyzynskiP , KrzymienJ , JozwickaE , BlachowiczJ , JanczewskaE , et al. What we can really expect from telemedicine in intensive diabetes treatment: results from 3‐year study on type 1 pregnant diabetic women. Diabetes Technology &amp; Therapeutics2001;3(4):581‐9. ">Wojcicki 2001</a>. In one trial, some outcomes reported in the protocol and methods of the trial report did not appear to have been adequately reported in the full trial report (<a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a>) and was considered to be at high risk for this domain. Most of the trials had small numbers of women; six trials (<a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Dalfr_x00e0_-2009" target="_blank">Dalfrà 2009</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Di-Biase-1997" target="_blank">Di Biase 1997</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Petrovski-2011" target="_blank">Petrovski 2011</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Stubbs-1980" target="_blank">Stubbs 1980</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Varner-1983" target="_blank">Varner 1983</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1903252011303808605149850721418%26format=REVMAN_GRAPHS#STD-Wojcicki-2001" target="_blank">Wojcicki 2001</a>) only had a range of 13 to 32 participants. Any potential bias is likely to have been overshadowed by the small number and size of trials with their different intervention techniques of monitoring and reported outcomes. The trials are too small to show differences in important outcomes such as macrosomia, preterm birth, miscarriage or death of baby. </p> <p>All the reported GRADE outcomes for comparisons 2, 3, 4, 5 and 6 were assessed as being very low‐quality evidence (<a href="./full#CD009613-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD009613-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD009613-tbl-0004">summary of findings Table 4</a>; <a href="./full#CD009613-tbl-0005">summary of findings Table 5</a>; <a href="./full#CD009613-tbl-0006">summary of findings Table 6</a>). We downgraded most outcomes in these tables once for serious concerns due to limitations in design and twice for very serious imprecision (wide confidence intervals (CIs) crossing the line of no effect, small sample sizes, and few events). </p> <p>Comparison 1 included more data than the other comparisons (four studies, 609 women), from studies assessed as being at lower risk of bias (<a href="./full#CD009613-tbl-0001">summary of findings Table for the main comparison</a>). Consequently, we graded caesarean section as moderate‐quality evidence with downgrading one level for serious inconsistency due to evidence of statistical heterogeneity. We graded hypertensive disorders of pregnancy as low‐quality evidence with downgrading two levels for serious limitations in study design and serious indirectness due to two studies reporting the composite outcome in different ways. We graded large‐for‐gestational as low quality with downgrading two levels due to serious imprecision (wide CI crossing line of no effect) and serious inconsistency (statistical heterogeneity). We graded perinatal mortality (stillbirth and neonatal mortality) as low quality with downgrading two levels for very serious imprecision due to evidence derived from a single study, with a small number of events and wide CI crossing the line of no effect. </p> <p>GRADE outcomes were often not reported. Caesarean section was the only GRADE outcome reported by studies in every comparison. The composite outcome of hypertensive disorders of pregnancy was only reported by studies in comparison 1. Large‐for‐gestational age was only reported by studies in comparisons 1 and 4. Perinatal mortality (stillbirth and neonatal mortality) was reported by studies in comparisons 1, 2, 3 and 4. </p> </section> <section id="CD009613-sec-0141"> <h3 class="title" id="CD009613-sec-0141">Potential biases in the review process</h3> <p>We attempted to minimise bias during the review process by having two people assess the eligibility of studies, assess risk of bias and extract data. GRADE quality assessments were also checked by a second person. We attempted to be as inclusive as possible in our search. However, we cannot rule out the possibility that we have missed relevant studies that were not published or are still ongoing. In addition, the proposed subgroup and sensitivity analyses could not be performed. </p> </section> <section id="CD009613-sec-0142"> <h3 class="title" id="CD009613-sec-0142">Agreements and disagreements with other studies or reviews</h3> <p>With the addition of two new studies (406 women) to one of the comparisons (comparison 1 ‐ continuous glucose monitoring (CGM) versus intermittent glucose monitoring), the evidence suggests that CGM may reduce hypertensive disorders of pregnancy, though as already stated, only two of the four relevant studies reported data for this composite outcome. Conversely, this did not translate into a clear reduction for pre‐eclampsia. CGM probably makes little or no difference to caesarean section, but may reduce neonatal hypoglycaemia. The findings from our review are on the whole very similar to another Cochrane Review (<a href="./references#CD009613-bbs2-0061" title="RamanP , ShepherdE , DowswellT , MiddletonP , CrowtherCA . Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD011069.pub2] ">Raman 2017</a>), which examined different methods and settings for glucose monitoring in gestational diabetes, and observed no clear differences between the CGM and self‐monitoring groups for any of their maternal or infant outcomes (caesarean section, large‐for‐gestational age, perinatal deaths). Hypertensive disorders of pregnancy were not reported by either study for their CGM comparison. The results for other comparisons were similar to findings from our review for telemedicine and self‐monitoring, in that there was insufficient evidence to show any clear effect for any of the outcomes examined (<a href="./references#CD009613-bbs2-0061" title="RamanP , ShepherdE , DowswellT , MiddletonP , CrowtherCA . Different methods and settings for glucose monitoring for gestational diabetes during pregnancy. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD011069.pub2] ">Raman 2017</a>). Other reviews also found limited evidence for the effectiveness of real‐time CGM use in children, adults and patients with poorly controlled diabetes (<a href="./references#CD009613-bbs2-0029" title="GhandiGY , KovalaskeM , KudvaY , WalshK , ElaminMB , BeersM , et al. Efﬁcacy of continuous glucose monitoring in improving glycaemic control and reducing hypoglycemia: a systematic review and meta analysis of randomized trials. Journal of Diabetes Science and Technology2011;5(4):952–65. ">Ghandi 2011</a>; <a href="./references#CD009613-bbs2-0048" title="LangendamM , LuijfYM , HooftL , DeVriesJH , MuddeAH , ScholtenRJ . Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews2012, Issue 1. [DOI: 10.1002/14651858.CD008101.pub2; CD008101] ">Langendam 2012</a>; <a href="./references#CD009613-bbs2-0060" title="PickupJC , FreemanSC , SuttonAJ . Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta‐analysis of randomised controlled trials using individual patient data. BMJ2011;343:d3805. ">Pickup 2011</a>). However, these reviews indicated that higher compliance of wearing the CGM device improves glycosylated haemoglobin A1c level (HbA1c) to a larger extent, and this is in line with our finding of a possible improvement in glycaemic control for women using CGM. </p> <p>There were no available reviews on self‐monitoring of blood glucose (SMBG) among pregnant women with pre‐existing diabetes and so the findings of this review cannot be compared with any other. This review's findings are not altogether consistent with the findings of others that considered methods for blood glucose monitoring techniques amongst other diabetic populations. SMBG has been found to be effective for patients with type 1 diabetes (<a href="./references#CD009613-bbs2-0024" title="The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. New England Journal of Medicine1993;329(14):977‐86. ">DCCT 1993</a>) and patients with type 2 diabetes who are using insulin (<a href="./references#CD009613-bbs2-0041" title="KarterAJ , AckersonLM , DarbinianJA , D'AgostinoRBJr , FerraraA , LiuJ , et al. Self‐monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. American Journal of Medicine2001;111(1):1‐9. ">Karter 2001</a>). One Cochrane Review (<a href="./references#CD009613-bbs2-0049" title="MalandaUL , WelschenLM , RiphagenII , DekkerJM , NijpelsG , BotSD . Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database of Systematic Reviews2012, Issue 1. [DOI: 10.1002/14651858.CD005060.pub3; CD005060] ">Malanda 2012</a>), concluded that SMBG in newly diagnosed patients with type 2 diabetes who are not using insulin is beneficial in lowering HbA1c. However, when the duration of diabetes is over one year, the overall glycaemic effects of SMBG are small at short term and subside after one year. </p> <p>Women with type 1 and type 2 diabetes are advised to self‐monitor their blood glucose throughout pregnancy (<a href="./references#CD009613-bbs2-0036" title="IDF . The Diabetes Atlas. Brussels: International Diabetes Federation, 2010. ">IDF 2010</a>). The control of hyperglycaemia in pregnant women with pre‐existing diabetes can reduce adverse maternal and infant outcomes (<a href="./references#CD009613-bbs2-0045" title="KitzmillerJL , BlockJM , BrownFM , CatalanoPM , ConwayDL , CoustanDR , et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care2008;31:1060‐79. ">Kitzmiller 2008</a>). A Cochrane Review has reported that pregnant women with type 1 or type 2 diabetes with tight to moderate glycaemic control had significantly lower risks for pre‐eclampsia, caesarean section and macrosomia (<a href="./references#CD009613-bbs2-0052" title="MiddletonP , CrowtherCA , SimmondsL . Different intensities of glycaemic control for pregnant women with pre‐existing diabetes. Cochrane Database of Systematic Reviews2016, Issue 5. [DOI: 10.1002/14651858.CD008540.pub4] ">Middleton 2016</a>). However, the evidence base for the relative effectiveness of monitoring techniques is inconclusive. </p> <p>Other than the above mentioned studies or reviews, we are not aware of any other published reviews on techniques of glucose monitoring among pregnant women with pre‐existing diabetes. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009613-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram 2018" data-id="CD009613-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram 2018</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009613-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009613-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 1 Hypertensive disorders of pregnancy." data-id="CD009613-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 1 Hypertensive disorders of pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 2 Caesarean section." data-id="CD009613-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 2 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 3 Large‐for‐gestational age." data-id="CD009613-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 3 Large‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 4 Perinatal mortality (stillbirth and neonatal mortality)." data-id="CD009613-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 4 Perinatal mortality (stillbirth and neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 5 Mortality or morbidity composite (pregnancy loss (miscarriage, stillbirth, and neonatal death); birth injury; neonatal glycaemia; hyperbilirubinaemia; respiratory distress; and high level neonatal care of more than 24 hours)." data-id="CD009613-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 5 Mortality or morbidity composite (pregnancy loss (miscarriage, stillbirth, and neonatal death); birth injury; neonatal glycaemia; hyperbilirubinaemia; respiratory distress; and high level neonatal care of more than 24 hours). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 6 Pre‐eclampsia." data-id="CD009613-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 6 Pre‐eclampsia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 7 Pregnancy‐induced hypertension." data-id="CD009613-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 7 Pregnancy‐induced hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 8 Behaviour changes associated with the intervention (range of score 10‐50 ‐ high score= greater fear of hypoglycaemia)." data-id="CD009613-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 8 Behaviour changes associated with the intervention (range of score 10‐50 ‐ high score= greater fear of hypoglycaemia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 9 Sense of well‐being and quality of life (Short form 12 (SF‐12), total score at 34 weeks' gestation)." data-id="CD009613-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 9 Sense of well‐being and quality of life (Short form 12 (SF‐12), total score at 34 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 10 Sense of well‐being and quality of life (Problem areas in diabetes (PAID), total score at 34 weeks' gestation)." data-id="CD009613-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 10 Sense of well‐being and quality of life (Problem areas in diabetes (PAID), total score at 34 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 11 Sense of well‐being and quality of life (BGMSRQ, total score at 34 weeks' gestation)." data-id="CD009613-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 11 Sense of well‐being and quality of life (BGMSRQ, total score at 34 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 12 Glycaemic control ‐ Maternal HbA1c." data-id="CD009613-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 12 Glycaemic control ‐ Maternal HbA1c. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 13 Glycaemic control ‐ Achieved maternal HbA1c &lt;= 6.5% (48 mmol/mol) at 34 weeks." data-id="CD009613-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 13 Glycaemic control ‐ Achieved maternal HbA1c &lt;= 6.5% (48 mmol/mol) at 34 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 14 Maternal hypoglycaemia (severe)." data-id="CD009613-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 14 Maternal hypoglycaemia (severe). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 15 Miscarriage." data-id="CD009613-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 15 Miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 16 Stillbirth." data-id="CD009613-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 16 Stillbirth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 17 Neonatal mortality." data-id="CD009613-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 17 Neonatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 18 Gestational age at birth." data-id="CD009613-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 18 Gestational age at birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 19 Preterm birth &lt; 37 weeks." data-id="CD009613-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 19 Preterm birth &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 20 Preterm birth &lt; 34 weeks." data-id="CD009613-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 20 Preterm birth &lt; 34 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 21 Macrosomia." data-id="CD009613-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 21 Macrosomia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 22 Birthweight." data-id="CD009613-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 22 Birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 23 Small‐for‐gestational age." data-id="CD009613-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 23 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 24 Head circumference (cm)." data-id="CD009613-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 24 Head circumference (cm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 25 Length (crown‐heel length cm)." data-id="CD009613-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 25 Length (crown‐heel length cm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 26 Adiposity (sum of 4 skin folds (tricepts, subscapular, biceps, flank) mm)." data-id="CD009613-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 26 Adiposity (sum of 4 skin folds (tricepts, subscapular, biceps, flank) mm). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 27 Shoulder dystocia." data-id="CD009613-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 27 Shoulder dystocia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 28 Respiratory distress syndrome." data-id="CD009613-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 28 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 29 Neonatal hypoglycaemia." data-id="CD009613-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 29 Neonatal hypoglycaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 30 Neonatal hyperbilirubinaemia." data-id="CD009613-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 30 Neonatal hyperbilirubinaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 31 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 566 pmol/L)." data-id="CD009613-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 31 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 566 pmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 32 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 2725 pmol/L)." data-id="CD009613-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 32 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 2725 pmol/L). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 33 Major and minor anomalies." data-id="CD009613-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 33 Major and minor anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 34 Number of hospital admissions (mother)." data-id="CD009613-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 34 Number of hospital admissions (mother). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 35 Neonatal intensive care unit admissions." data-id="CD009613-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 35 Neonatal intensive care unit admissions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 36 Neonatal intensive care unit length of admission &gt; 24 hours." data-id="CD009613-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 36 Neonatal intensive care unit length of admission &gt; 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 37 Birth trauma (shoulder dystocia, bone fracture, nerve palsy)." data-id="CD009613-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 37 Birth trauma (shoulder dystocia, bone fracture, nerve palsy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 38 Diabetic ketoacidosis (mother)." data-id="CD009613-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Continuous glucose monitoring versus intermittent glucose monitoring, Outcome 38 Diabetic ketoacidosis (mother). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 1 Caesarean section." data-id="CD009613-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 2 Perinatal mortality (stillbirth and neonatal mortality)." data-id="CD009613-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 2 Perinatal mortality (stillbirth and neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 3 Glycaemic control during/end of treatment (maternal post‐prandial blood glucose)." data-id="CD009613-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 3 Glycaemic control during/end of treatment (maternal post‐prandial blood glucose). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 4 Glycaemic control during/end of treatment (maternal HbA1c)." data-id="CD009613-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 4 Glycaemic control during/end of treatment (maternal HbA1c). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 5 Miscarriage." data-id="CD009613-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 5 Miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 6 Neonatal mortality." data-id="CD009613-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 6 Neonatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 7 Gestational age at birth." data-id="CD009613-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 7 Gestational age at birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 8 Birthweight." data-id="CD009613-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 8 Birthweight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 9 Respiratory distress syndrome." data-id="CD009613-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 9 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 10 Neonatal hypoglycaemia." data-id="CD009613-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 10 Neonatal hypoglycaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 11 Neonatal jaundice (hyperbilirubinaemia)." data-id="CD009613-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 11 Neonatal jaundice (hyperbilirubinaemia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 12 Neonatal hypocalcaemia." data-id="CD009613-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 12 Neonatal hypocalcaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 13 Neonatal polycythaemia." data-id="CD009613-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 13 Neonatal polycythaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 14 Neonatal cord vein C‐peptide." data-id="CD009613-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Self‐monitoring versus different type of self monitoring, Outcome 14 Neonatal cord vein C‐peptide. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 1 Hypertensive disorders of pregnancy." data-id="CD009613-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 1 Hypertensive disorders of pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 2 Caesarean section." data-id="CD009613-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 2 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 3 Perinatal mortality (stillbirth and neonatal mortality)." data-id="CD009613-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 3 Perinatal mortality (stillbirth and neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 4 Pre‐eclampsia." data-id="CD009613-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 4 Pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 5 Pregnancy‐induced hypertension." data-id="CD009613-fig-0060" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 5 Pregnancy‐induced hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 6 Placental abruption." data-id="CD009613-fig-0061" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 6 Placental abruption.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 7 Preterm birth &lt; 37 weeks." data-id="CD009613-fig-0062" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 7 Preterm birth &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 8 Respiratory distress syndrome." data-id="CD009613-fig-0063" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 8 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 9 Neonatal hypoglycaemia." data-id="CD009613-fig-0064" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 9 Neonatal hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 10 Neonatal jaundice (hyperbilirubinaemia)." data-id="CD009613-fig-0065" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 10 Neonatal jaundice (hyperbilirubinaemia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 11 Major anomalies." data-id="CD009613-fig-0066" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 11 Major anomalies.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 12 Antenatal hospital admission." data-id="CD009613-fig-0067" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 12 Antenatal hospital admission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 13 Feeding difficulties (not pre‐specified)." data-id="CD009613-fig-0068" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Self‐monitoring at home versus hospitalisation, Outcome 13 Feeding difficulties (not pre‐specified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 1 Caesarean section." data-id="CD009613-fig-0069" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 2 Large‐for‐gestational age." data-id="CD009613-fig-0070" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 2 Large‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 3 Perinatal mortality (stillbirth and neonatal mortality)." data-id="CD009613-fig-0071" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 3 Perinatal mortality (stillbirth and neonatal mortality). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 4 Pre‐eclampsia." data-id="CD009613-fig-0072" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 4 Pre‐eclampsia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 5 Weight gain during pregnancy." data-id="CD009613-fig-0073" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 5 Weight gain during pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 6 Insulin dose." data-id="CD009613-fig-0074" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 6 Insulin dose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 7 Glycaemic control ‐ Insulin dose." data-id="CD009613-fig-0075" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 7 Glycaemic control ‐ Insulin dose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 8 Glycaemic control ‐ HbA1c." data-id="CD009613-fig-0076" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 8 Glycaemic control ‐ HbA1c. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 9 Stillbirth." data-id="CD009613-fig-0077" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 9 Stillbirth.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 10 Gestational age at birth." data-id="CD009613-fig-0078" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 10 Gestational age at birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 11 Preterm birth &lt; 37 weeks." data-id="CD009613-fig-0079" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 11 Preterm birth &lt; 37 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 12 Macrosomia." data-id="CD009613-fig-0080" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 12 Macrosomia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 13 Birthweight." data-id="CD009613-fig-0081" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 13 Birthweight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 14 Adiposity ‐ Subscapula skinfold thickness." data-id="CD009613-fig-0082" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 14 Adiposity ‐ Subscapula skinfold thickness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 15 Adiposity ‐ Triceps skinfold thickness." data-id="CD009613-fig-0083" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 15 Adiposity ‐ Triceps skinfold thickness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 16 Birth trauma (shoulder dystocia, bone fracture, nerve palsy) (not pre‐specified as a composite)." data-id="CD009613-fig-0084" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 16 Birth trauma (shoulder dystocia, bone fracture, nerve palsy) (not pre‐specified as a composite). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 17 Respiratory distress syndrome." data-id="CD009613-fig-0085" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 17 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 18 Neonatal hypoglycaemia." data-id="CD009613-fig-0086" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 18 Neonatal hypoglycaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 19 Neonatal jaundice (hyperbilirubinaemia)." data-id="CD009613-fig-0087" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 19 Neonatal jaundice (hyperbilirubinaemia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 20 Cord IGF‐1." data-id="CD009613-fig-0088" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.20</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 20 Cord IGF‐1. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 21 Neonatal glucose at age 1 hour (not pre‐specified)." data-id="CD009613-fig-0089" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.21</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 21 Neonatal glucose at age 1 hour (not pre‐specified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 22 Transient tachypnea (not pre‐specified)." data-id="CD009613-fig-0090" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.22</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 22 Transient tachypnea (not pre‐specified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-004-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-004-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 23 Neonatal intensive care admissions." data-id="CD009613-fig-0091" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.23</div> <div class="figure-caption"> <p>Comparison 4 Pre‐prandial versus post‐prandial glucose monitoring, Outcome 23 Neonatal intensive care admissions. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-004-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 1 Caesarean section." data-id="CD009613-fig-0092" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 1 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 2 Neonatal morbidity composite." data-id="CD009613-fig-0093" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 2 Neonatal morbidity composite. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 3 Gestational age at birth." data-id="CD009613-fig-0094" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 3 Gestational age at birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 4 Use of additional insulin therapy." data-id="CD009613-fig-0095" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 4 Use of additional insulin therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 5 Insulin requirement at end of study." data-id="CD009613-fig-0096" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 5 Insulin requirement at end of study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 6 Glycaemic control ‐ Maternal fasting blood glucose: before breakfast." data-id="CD009613-fig-0097" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 6 Glycaemic control ‐ Maternal fasting blood glucose: before breakfast. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 7 Glycaemic control ‐ Maternal fasting blood glucose: before lunch." data-id="CD009613-fig-0098" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 7 Glycaemic control ‐ Maternal fasting blood glucose: before lunch. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 8 Glycaemic control ‐ Maternal HbA1c." data-id="CD009613-fig-0099" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 8 Glycaemic control ‐ Maternal HbA1c. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 9 Glycaemic control ‐ Maternal post‐prandial blood glucose." data-id="CD009613-fig-0100" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 9 Glycaemic control ‐ Maternal post‐prandial blood glucose. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 10 Weight gain during pregnancy [kg]." data-id="CD009613-fig-0101" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 10 Weight gain during pregnancy [kg]. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 11 Macrosomia." data-id="CD009613-fig-0102" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 11 Macrosomia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-005-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-005-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 12 Birthweight." data-id="CD009613-fig-0103" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Automated telemedicine monitoring versus conventional, Outcome 12 Birthweight.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-005-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 1 Caesarean section." data-id="CD009613-fig-0104" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 1 Caesarean section.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 2 Weight gain during pregnancy." data-id="CD009613-fig-0105" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 2 Weight gain during pregnancy.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 3 Insulin dosage, 3rd trimester (IU/kg/day)." data-id="CD009613-fig-0106" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 3 Insulin dosage, 3<sup>rd</sup> trimester (IU/kg/day). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 4 Glycaemic control ‐ Maternal blood glucose (1st trimester)." data-id="CD009613-fig-0107" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 4 Glycaemic control ‐ Maternal blood glucose (1st trimester). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 5 Glycaemic control ‐ Maternal blood glucose (3rd trimester)." data-id="CD009613-fig-0108" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 5 Glycaemic control ‐ Maternal blood glucose (3rd trimester). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 6 Glycaemic control ‐ Maternal HbA1c (1st trimester)." data-id="CD009613-fig-0109" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 6 Glycaemic control ‐ Maternal HbA1c (1st trimester). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 7 Glycaemic control ‐ Maternal HbA1c (3rd trimester)." data-id="CD009613-fig-0110" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 7 Glycaemic control ‐ Maternal HbA1c (3rd trimester). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 8 Maternal hypoglycemia." data-id="CD009613-fig-0111" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 8 Maternal hypoglycemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 9 Diabetic ketoacidosis (not pre‐specified)." data-id="CD009613-fig-0112" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 9 Diabetic ketoacidosis (not pre‐specified). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 10 Preterm birth &lt; 37 weeks." data-id="CD009613-fig-0113" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 10 Preterm birth &lt; 37 weeks.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 11 Macrosomia." data-id="CD009613-fig-0114" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 11 Macrosomia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009613-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/urn:x-wiley:14651858:media:CD009613:CD009613-CMP-006-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_t/tCD009613-CMP-006-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Constant CGM versus intermittent CGM, Outcome 12 Neonatal hypoglycaemia." data-id="CD009613-fig-0115" src="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6 Constant CGM versus intermittent CGM, Outcome 12 Neonatal hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/media/CDSR/CD009613/image_n/nCD009613-CMP-006-12.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a hospital centre for pregnant women with diabetes in Denmark, 1 study in two secondary care multi‐disciplinary obstetric diabetic clinics in the UK, 1 multi‐centre study in 31 hospital and diabetic clinics in Canada, England, Scotland, Spain, Italy, Ireland and the USA, and 1 multi‐centre study in 22 hospital outpatient obstetric and endocrinology clinics (university, teaching and non‐teaching in the Netherlands and 1 university hospital in Belgium). </p> <p><b>Intervention:</b> continuous glucose monitoring<br/> <b>Comparison:</b> intermittent glucose monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intermittent self‐glucose monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with continuous glucose monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.39 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>384<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>292 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>170 per 1000<br/> (114 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.94<br/> (0.75 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>427<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE<sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>564 per 1000<br/> (450 to 708) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.84<br/> (0.57 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>421<br/> (3 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>546 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>459 per 1000<br/> (311 to 688) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.82<br/> (0.05 to 12.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>71<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>31 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (2 to 394) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear risk of allocation concealment and high risk for selective outcome reporting </p> <p><sup>2</sup> We downgraded (1) level for serious indirectness due to the two studies reporting this composite outcome in different ways: <a href="./references#CD009613-bbs2-0011" title="EversI . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. Diabetes Technology and Therapeutics2016;18:A13‐A14. VoormolenDN , DeVriesJH , FranxA , MolBW , EversIM . Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial. BMC Pregnancy and Childbirth2012;12:164. VoormolenDN , DeVriesJH , SansonRM , HeringaMP , deValkHW , KokM , et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial. Diabetes, Obesity &amp; Metabolism2018;20(8):1894‐902. VoormolenDN , HeringaMP , NaaktgeborenCA , FranxA , DeVriesJH , KokM , et al. Efficacy of continuous glucose monitoring in diabetic pregnancy, the glucomoms trial. American Journal of Obstetrics and Gynecology2017;216(1):S288, Abstract no: 488. ">Voormolen 2018</a> reported a composite of pregnancy‐induced hypertension and pre‐eclampsia for women with type 1 diabetes and type 2 diabetes for; and <a href="./references#CD009613-bbs2-0003" title="FarrellA , MerglerS , MasonD , SanchezJ , FeigDS , AsztalosE . The use of logs and forms for the tracking of RT‐CGM devices in the CONCEPTT Trial. Clinical Trials2013;10:S80. FeigDS , AsztalosE , CorcoyR , DeLeivaA , DonovanL , HodM , et al. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi‐center, multi‐national, randomized controlled trial ‐ Study protocol. BMC Pregnancy and Childbirth2016;16(1):167. [PUBMED: 27430714] FeigDS , DonovanLE , CorcoyR , MurphyKE , AmielSA , HuntKF , et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (conceptt): a multicentre international randomised controlled trial. Lancet2017;390(10110):2347‐59. NCT01788527 . Continuous glucose monitoring in women with type 1 diabetes in pregnancy trial (CONCEPTT). clinicaltrials.gov/show/NCT01788527 Date first received: 19 December 2012. ">Feig 2017</a> reporting a composite of worsening chronic, gestational and pre‐eclampsia for women with type 1 diabetes </p> <p><sup>3</sup> We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity I<sup>2</sup> = 41% </p> <p><sup>4</sup> We downgraded (1) level for serious imprecision due to wide CI crossing the line of no effect </p> <p><sup>5</sup> We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity I<sup>2</sup> = 70% </p> <p><sup>6</sup> We downgrade (2) levels for very serious imprecision due to evidence derived from a single study, with a small number of events, wide CI crossing the line of no effect </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Continuous glucose monitoring compared to intermittent glucose monitoring for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring compared to a different type of self‐monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Self‐monitoring compared to standard care for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a high‐risk obstetric clinic at University hospital in the USA<br/> <b>Intervention:</b> self‐monitoring<br/> <b>Comparison:</b> standard care </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with standard care</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with self‐monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.78<br/> (0.40 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>643 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>501 per 1000<br/> (257 to 958) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.00<br/> (0.13 to 67.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the standard care group and so anticipated absolute effects could not be calculated. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in design limitations due unclear allocation concealment and high risk for attrition </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Self‐monitoring compared to a different type of self‐monitoring for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Self‐monitoring at home compared to hospitalisation for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Self‐monitoring compared to hospitalisation for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in Sweden with monitoring at home or in hospital<br/> <b>Intervention:</b> self‐monitoring<br/> <b>Comparison:</b> hospitalisation </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with hospitalisation</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with self‐monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.19</p> <p>(0.41 to 3.51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>129 per 1000</p> <p>(45 to 381)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.65 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>480 per 1000<br/> (325 to 720) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/> (0.05 to 13.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>100<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>18 per 1000<br/> (1 to 288) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear randomisation, allocation concealment and high risk for attrition </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Self‐monitoring at home compared to hospitalisation for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in a joint metabolic and antenatal clinic in Belfast </p> <p><b>Intervention:</b> pre‐prandial<br/> <b>Comparison:</b> post‐prandial glucose monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with post‐prandial glucose monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with pre‐prandial</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this composite outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.45<br/> (0.92 to 2.28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>467 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>677 per 1000<br/> (429 to 1000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.16<br/> (0.73 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580 per 1000<br/> (365 to 925) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.91<br/> (0.12 to 68.66) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>61<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were no events in the standard care group and so anticipated absolute effects could not be calculated. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in study design due to unclear methods of randomisation and high risk of attrition </p> <p><sup>2</sup> We downgrade (2) levels for very serious limitations in imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Pre‐prandial compared to post‐prandial glucose monitoring for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 2 studies in antenatal diabetic clinics in Italy, 1 study in gastroenterology and metabolic diseases clinic in Poland<br/> <b>Intervention:</b> automated telemedicine monitoring<br/> <b>Comparison:</b> conventional monitoring </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with conventional monitoring</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with automated telemedicine monitoring</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this composite outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.96<br/> (0.62 to 1.48) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>733 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>704 per 1000<br/> (455 to 1000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included studies did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (2) levels for very serious design limitations due to high risk for randomisation, allocation concealment, attrition and other bias </p> <p><sup>2</sup> We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Automated telemedicine monitoring compared to conventional for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009613-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> women with pre‐existing diabetes<br/> <b>Setting:</b> 1 study in University clinic of endocrinology, diabetes and metabolic disorders in Macedonia<br/> <b>Intervention:</b> constant CGM<br/> <b>Comparison:</b> intermittent CGM </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Intermittent CGM</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with constant CGM</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.77<br/> (0.33 to 1.79) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>25<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>538 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>415 per 1000<br/> (178 to 964) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Large‐for‐gestational age</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>(0 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>The included study did not report this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> We downgraded (1) level for serious limitations in design due to unclear randomisation and allocation concealment </p> <p><sup>2</sup> We downgraded (2) levels for very serious limitations in imprecision due to wide CI crossing the line of no effect, few events and small sample size </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Constant CGM compared to Intermittent CGM for women with pre‐existing diabetes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/full#CD009613-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Continuous glucose monitoring versus intermittent glucose monitoring</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Hypertensive disorders of pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.39, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.75, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Large‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.57, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Perinatal mortality (stillbirth and neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.05, 12.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mortality or morbidity composite (pregnancy loss (miscarriage, stillbirth, and neonatal death); birth injury; neonatal glycaemia; hyperbilirubinaemia; respiratory distress; and high level neonatal care of more than 24 hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.61, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>609</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.39, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pregnancy‐induced hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>384</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.38, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Behaviour changes associated with the intervention (range of score 10‐50 ‐ high score= greater fear of hypoglycaemia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐1.06, 3.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Sense of well‐being and quality of life (Short form 12 (SF‐12), total score at 34 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐2.50, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Sense of well‐being and quality of life (Problem areas in diabetes (PAID), total score at 34 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐3.06, 4.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Sense of well‐being and quality of life (BGMSRQ, total score at 34 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.30 [0.73, 7.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Glycaemic control ‐ Maternal HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.37 [‐0.78, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Glycaemic control ‐ Achieved maternal HbA1c &lt;= 6.5% (48 mmol/mol) at 34 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.00, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal hypoglycaemia (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.43, 1.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.47, 3.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Neonatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.13, 6.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Gestational age at birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.57, 0.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Preterm birth &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>430</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.72, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Preterm birth &lt; 34 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.17, 1.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Macrosomia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.61, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.38, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>269</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [0.55, 10.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Head circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.79, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Length (crown‐heel length cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.79, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Adiposity (sum of 4 skin folds (tricepts, subscapular, biceps, flank) mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.98, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Shoulder dystocia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 72.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.41, 2.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.48, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Neonatal hyperbilirubinaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.52, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 566 pmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.68, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Relevant biomarker changes associated with the intervention (cord blood c‐peptide levels &gt; 2725 pmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.33, 3.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Major and minor anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.16, 3.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Number of hospital admissions (mother) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.84, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Neonatal intensive care unit admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.42, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Neonatal intensive care unit length of admission &gt; 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.42, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Birth trauma (shoulder dystocia, bone fracture, nerve palsy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.24, 102.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Diabetic ketoacidosis (mother) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.14, 7.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Continuous glucose monitoring versus intermittent glucose monitoring</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Self‐monitoring versus different type of self monitoring</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.40, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Perinatal mortality (stillbirth and neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 67.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Glycaemic control during/end of treatment (maternal post‐prandial blood glucose) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐2.15, 0.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Glycaemic control during/end of treatment (maternal HbA1c) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐1.93, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Neonatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 67.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Gestational age at birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐1.65, 2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.49, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 67.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.21, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal jaundice (hyperbilirubinaemia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.25, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal hypocalcaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.07, 14.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Neonatal polycythaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Neonatal cord vein C‐peptide <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.50, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Self‐monitoring versus different type of self monitoring</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Self‐monitoring at home versus hospitalisation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Hypertensive disorders of pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.41, 3.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.65, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Perinatal mortality (stillbirth and neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.05, 13.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.26 [0.52, 35.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pregnancy‐induced hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.08, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Placental abruption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.16, 18.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Preterm birth &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.45, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.28, 23.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.50, 2.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal jaundice (hyperbilirubinaemia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [0.64, 8.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Major anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.03, 2.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Antenatal hospital admission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.11, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Feeding difficulties (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.41, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Self‐monitoring at home versus hospitalisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Pre‐prandial versus post‐prandial glucose monitoring</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.92, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Large‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.73, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Perinatal mortality (stillbirth and neonatal mortality) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.91 [0.12, 68.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pre‐eclampsia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.43 [0.82, 50.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Weight gain during pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐3.86, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐17.40 [‐43.41, 8.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Glycaemic control ‐ Insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.45, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Glycaemic control ‐ HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.08, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Stillbirth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.91 [0.12, 68.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Gestational age at birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.84, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Preterm birth &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.62, 2.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Macrosomia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [0.75, 6.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.10, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Adiposity ‐ Subscapula skinfold thickness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐0.18, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Adiposity ‐ Triceps skinfold thickness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.04, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Birth trauma (shoulder dystocia, bone fracture, nerve palsy) (not pre‐specified as a composite) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 5.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.06, 14.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.48, 2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Neonatal jaundice (hyperbilirubinaemia) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.40, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Cord IGF‐1 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [‐0.70, 3.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Neonatal glucose at age 1 hour (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.88, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Transient tachypnea (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.58 [0.76, 8.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Neonatal intensive care admissions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.62, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Pre‐prandial versus post‐prandial glucose monitoring</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Automated telemedicine monitoring versus conventional</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.62, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal morbidity composite <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.53, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Gestational age at birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.39, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Use of additional insulin therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.89, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Insulin requirement at end of study <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>18.4 [12.88, 23.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Glycaemic control ‐ Maternal fasting blood glucose: before breakfast <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐1.22, ‐0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Glycaemic control ‐ Maternal fasting blood glucose: before lunch <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐1.32, ‐0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Glycaemic control ‐ Maternal HbA1c <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.82, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Glycaemic control ‐ Maternal post‐prandial blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.67, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Weight gain during pregnancy [kg] <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐4.95, 3.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Macrosomia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.31, 4.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.64, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Automated telemedicine monitoring versus conventional</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009613-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Constant CGM versus intermittent CGM</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.33, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Weight gain during pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐1.82, 2.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Insulin dosage, 3<sup>rd</sup> trimester (IU/kg/day) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐1.30, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Glycaemic control ‐ Maternal blood glucose (1st trimester) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐2.70, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Glycaemic control ‐ Maternal blood glucose (3rd trimester) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐2.00, 1.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Glycaemic control ‐ Maternal HbA1c (1st trimester) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.13, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Glycaemic control ‐ Maternal HbA1c (3rd trimester) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.69, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal hypoglycemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.06, 5.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Diabetic ketoacidosis (not pre‐specified) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Preterm birth &lt; 37 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.08, 15.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Macrosomia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.08, 15.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Constant CGM versus intermittent CGM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009613.pub4/references#CD009613-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009613.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009613-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009613-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009613-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009613-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009613-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009613-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD009613-note-0002">Português</a> </li> <li class="section-language"> <a class="" href="th#CD009613-note-0003">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009613-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009613-note-0008">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009613\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009613\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009613\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009613\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009613\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009613.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009613.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009613.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009613.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009613.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717579781"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009613.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717579785"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009613.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbb61ab0b9371',t:'MTc0MDcxNzU4MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 